<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Philos Trans R Soc Lond B Biol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Philos. Trans. R. Soc. Lond., B, Biol. Sci</journal-id>
<journal-id journal-id-type="publisher-id">RSTB</journal-id>
<journal-id journal-id-type="hwp">royptb</journal-id>
<journal-title-group>
<journal-title>Philosophical Transactions of the Royal Society B: Biological Sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">0962-8436</issn>
<issn pub-type="epub">1471-2970</issn>
<publisher>
<publisher-name>The Royal Society</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30397099</article-id>
<article-id pub-id-type="pmc">6232586</article-id>
<article-id pub-id-type="doi">10.1098/rstb.2018.0162</article-id>
<article-id pub-id-type="publisher-id">rstb20180162</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>1001</subject>
<subject>129</subject>
<subject>15</subject>
<subject>33</subject>
<subject>197</subject>
<subject>201</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
<subj-group subj-group-type="leader">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Terminal nucleotidyl transferases (TENTs) in mammalian RNA metabolism</article-title>
<alt-title alt-title-type="short">Mammalian ncPAPs and TUTases</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-1684-1635</contrib-id>
<name>
<surname>Warkocki</surname>
<given-names>Zbigniew</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liudkovska</surname>
<given-names>Vladyslava</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gewartowska</surname>
<given-names>Olga</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mroczek</surname>
<given-names>Seweryn</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-8492-7572</contrib-id>
<name>
<surname>Dziembowski</surname>
<given-names>Andrzej</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
<xref ref-type="corresp" rid="cor2"></xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label><institution>Department of RNA Metabolism, Institute of Bioorganic Chemistry, Polish Academy of Sciences</institution>, <addr-line>Noskowskiego 12/14, Poznan</addr-line>, <country>Poland</country></aff>
<aff id="af2"><label>2</label><institution>Laboratory of RNA Biology and Functional Genomics, Institute of Biochemistry and Biophysics, Polish Academy of Sciences</institution>, <addr-line>Pawinskiego 5a, 02-106 Warsaw</addr-line>, <country>Poland</country></aff>
<aff id="af3"><label>3</label><institution>Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw</institution>, <addr-line>Pawinskiego 5a, 02-106 Warsaw</addr-line>, <country>Poland</country></aff>
<author-notes>
<corresp id="cor1">e-mail: <email>zwarkocki@ibch.poznan.pl</email></corresp>
<corresp id="cor2">e-mail: <email>andrzejd@ibb.waw.pl</email></corresp>
<fn fn-type="other">
<p>One contribution of 11 to a theme issue ‘<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1098/rstb/373/1762">5′ and 3′ modifications controlling RNA degradation</ext-link>’.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>19</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>5</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>5</day>
<month>11</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>373</volume>
<issue>1762</issue>
<issue-title>Theme issue ‘5′ and 3′ modifications controlling RNA degradation’ organized and edited by Dominique Gagliardi and Andrzej Dziembowski</issue-title>
<elocation-id>20180162</elocation-id>
<history>
<date date-type="accepted">
<day>1</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 The Authors.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>Published by the Royal Society under the terms of the Creative Commons Attribution License <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>, which permits unrestricted use, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="rstb20180162.pdf"></self-uri>
<abstract>
<p>In eukaryotes, almost all RNA species are processed at their 3′ ends and most mRNAs are polyadenylated in the nucleus by canonical poly(A) polymerases. In recent years, several terminal nucleotidyl transferases (TENTs) including non-canonical poly(A) polymerases (ncPAPs) and terminal uridyl transferases (TUTases) have been discovered. In contrast to canonical polymerases, TENTs' functions are more diverse; some, especially TUTases, induce RNA decay while others, such as cytoplasmic ncPAPs, activate translationally dormant deadenylated mRNAs. The mammalian genome encodes 11 different TENTs. This review summarizes the current knowledge about the functions and mechanisms of action of these enzymes.</p>
<p>This article is part of the theme issue ‘5′ and 3′ modifications controlling RNA degradation’.</p>
</abstract>
<kwd-group>
<kwd>TENT</kwd>
<kwd>non-canonical polyadenylation</kwd>
<kwd>RNA uridylation</kwd>
<kwd>TUTase</kwd>
<kwd>RNA stability</kwd>
<kwd>RNA metabolism</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>European Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>309419</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Foundation for Polish Science</institution>
</institution-wrap>
</funding-source>
<award-id>TEAM/2016-1/3</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Narodowe Centrum Nauki</institution>
<institution-id>http://dx.doi.org/10.13039/501100004281</institution-id>
</institution-wrap>
</funding-source>
<award-id>2017/26/D/NZ1/00887</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>December 19, 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1">
<label>1.</label>
<title>Introduction</title>
<p>Eukaryotic gene expression pathways are very complex and regulated at multiple levels. Essentially all RNAs are processed at their 3′ ends and most coding mRNAs, as well as some non-coding RNAs (ncRNAs), are polyadenylated in the nucleus by canonical poly(A) polymerases at the end of transcription. In recent years, 11 TErminal NucleotidylTransferases (TENTs) have been discovered (<xref ref-type="fig" rid="RSTB20180162F1">figure 1</xref>) [<xref ref-type="bibr" rid="RSTB20180162C1">1</xref>–<xref ref-type="bibr" rid="RSTB20180162C3">3</xref>]. TENTs contain a particular catalytic fold that is defined by InterPro as a nucleotidyl transferase domain (IPR005835 or PF00483) belonging to the DNA polymerase β (Pol β) superfamily that could catalyse non-templated nucleotide additions to RNA 3′ ends [<xref ref-type="bibr" rid="RSTB20180162C1">1</xref>,<xref ref-type="bibr" rid="RSTB20180162C4">4</xref>,<xref ref-type="bibr" rid="RSTB20180162C5">5</xref>]. Based on their substrate preference towards adenosine monophosphate (AMP) or uridine monophosphate (UMP) incorporation, human TENTs are divided into non-canonical poly(A) polymerases (ncPAPs) and terminal uridyl transferases (TUTases), while phylogenetic analysis groups them into seven families [<xref ref-type="bibr" rid="RSTB20180162C4">4</xref>,<xref ref-type="bibr" rid="RSTB20180162C5">5</xref>]. TENTs share a common two-metal ion catalytic mechanism involving a highly conserved triad of aspartate residues in their catalytic helix-turn motif [<xref ref-type="bibr" rid="RSTB20180162C6">6</xref>–<xref ref-type="bibr" rid="RSTB20180162C10">10</xref>]. TENTs are not restricted to the nucleus and have specific regulatory roles also in the cytoplasm and mitochondria. Indeed, their functions are quite diverse and range from RNA maturation and decay to activation of translationally dormant deadenylated mRNAs. The exploration of TENTs' impact on the regulation of gene expression has become a rapidly growing field of research. Recently, the nomenclature of human TENTs and their orthologues across vertebrates has been updated and is presented in <xref ref-type="fig" rid="RSTB20180162F1">figure 1</xref> and used throughout the paper. In this review, we discuss the current state of knowledge regarding mammalian TENTs.
<fig id="RSTB20180162F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>A display of mammalian TENTs. The display summarizes major facts about 11 mammalian TENTs. The enzymes fall within two major classes: poly(A) polymerases (highlighted in green) and poly(U) polymerases (highlighted in yellow and pink). Their homologues can be further grouped into seven families based on their phylogenetic conservation (separated by dashed lines and/or coloured background). The display states protein names according to currently recommended terminology, the multiple aliases, protein molecular weights (in kDa) and number of amino acids within the canonical isoform (after <uri xlink:href="http://dx.doi.org/uniprot.org">uniprot.org</uri>), activities and targeted RNA types. Additionally, a cartoon representation of each protein (or a consensus representation for the TENT5 proteins) is provided with indicated domains that are colour-coded and labelled as follows (in alphabetical order): KA-1—kinase associated domain (in TENT1), MTS—mitochondria targeting signal/peptide, NLS—nuclear localization signal, NTr—catalytic nucleotidyltransferase domain (or an inactive domain), PAP-associated domain, Pneumo G and atrophin-like domains in TUT4, RRM—RNA recognition motif, ZNF—zinc finger domain of either C2H2 or CCHC types. snRNA, small nuclear RNA.</p></caption><graphic xlink:href="rstb20180162-g1"></graphic></fig></p>
</sec>
<sec id="s2">
<label>2.</label>
<title>ncPAPs and adenylation</title>
<p>The best-known example of non-templated adenylation is at 3′ ends of the vast majority of protein-coding mRNAs. This phenomenon, first realized in the early 1970s, is represented by the activity of two nuclear ‘canonical’ poly(A) polymerases—PAPα and PAPγ, and a great number of other auxiliary, structural and enzymatic factors as reviewed in detail elsewhere [<xref ref-type="bibr" rid="RSTB20180162C11">11</xref>–<xref ref-type="bibr" rid="RSTB20180162C13">13</xref>]. The primary role of the poly(A) tail is to protect an mRNA's 3′ end from degradation, thus contributing to its stability and increased translation rate [<xref ref-type="bibr" rid="RSTB20180162C14">14</xref>]. The existence of ncPAPs came with the discovery of cytoplasmic polyadenylation regulating the timing of mRNA translation and stability in developing <italic>Caenorhabditis elegans</italic> and <italic>Xenopus laevis</italic> embryos by TENT2 protein (GLD2) [<xref ref-type="bibr" rid="RSTB20180162C15">15</xref>,<xref ref-type="bibr" rid="RSTB20180162C16">16</xref>]. In this part of the review, we describe the eight mammalian ncPAPs, including some crucial findings about their homologues in other organisms.</p>
<sec id="s2a">
<label>(a)</label>
<title>TENT2, also known as FLJ38499, GLD2, PAPD4, TUT2</title>
<p>The bulk of the data on TENT2 came from studies in non-mammalian species, including <italic>C. elegans</italic>, <italic>X. laevis</italic> and <italic>Drosophila melanogaster</italic>. In these organisms, TENT2 was first described as a ncPAP with a key role in translational activation of a subset of cytoplasmic mRNAs through elongation of their poly(A) tails [<xref ref-type="bibr" rid="RSTB20180162C15">15</xref>–<xref ref-type="bibr" rid="RSTB20180162C17">17</xref>]. The functional regulation of mRNA translation in gametes and early embryos in these organisms is accomplished by highly regulated polyadenylation–deadenylation cycles that, besides TENT2, involve several other factors [<xref ref-type="bibr" rid="RSTB20180162C16">16</xref>–<xref ref-type="bibr" rid="RSTB20180162C27">27</xref>]. There are comprehensive reviews on the role of TENT2 in gametogenesis and early development in non-mammalian species [<xref ref-type="bibr" rid="RSTB20180162C28">28</xref>–<xref ref-type="bibr" rid="RSTB20180162C30">30</xref>].</p>
<p>On the basis of the discoveries in <italic>C. elegans</italic> and <italic>X. laevis</italic> it seemed likely that TENT2 is involved in gametogenesis and early embryo development in mammals. This was further supported by the heterologous translation activator activity of human TENT2 tethered to a reporter mRNA and injected into <italic>X. laevis</italic> oocytes [<xref ref-type="bibr" rid="RSTB20180162C31">31</xref>]. In line with this hypothesis, knock-down or overexpression of TENT2 in mice oocytes results in a delay of their maturation and frequent arrest in metaphase I [<xref ref-type="bibr" rid="RSTB20180162C32">32</xref>]. Surprisingly, TENT2-deficient mice of both sexes are fertile and do not demonstrate any gross phenotype. The maturation of oocytes is normal and the length of poly(A) tails of the reporter mRNA is altered neither in germline nor in somatic cells [<xref ref-type="bibr" rid="RSTB20180162C33">33</xref>]. This raises a possibility that in mammalian early embryos other yet unidentified TENT protein(s) might be involved in poly(A) length regulation [<xref ref-type="bibr" rid="RSTB20180162C34">34</xref>] or that other processes like regulation of mRNA decay by uridylation-mediated mechanisms (see §3b on TUTases) play decisive roles [<xref ref-type="bibr" rid="RSTB20180162C35">35</xref>].</p>
<p>On an organismal level, besides a possible auxiliary role in early embryo development, TENT2 may also be necessary for long-term memory formation in mice as it is expressed in the hippocampus and co-localizes with proteins involved in synaptic plasticity, such as Pumilio and CPEB1 [<xref ref-type="bibr" rid="RSTB20180162C17">17</xref>]. TENT2 was shown to polyadenylate GluN2A mRNA encoding a subunit of the postsynaptic N-methyl-<sc>d</sc>-aspartate receptor, crucial for synaptic plasticity in rat hippocampal neurons [<xref ref-type="bibr" rid="RSTB20180162C36">36</xref>]. Furthermore, TENT2 polyadenylates hnRNPA1, p27kip1 and β-catenin mRNAs in human 293T cells [<xref ref-type="bibr" rid="RSTB20180162C37">37</xref>], which might play some role in cell cycle regulation in agreement with some earlier findings in <italic>X. laevis</italic> [<xref ref-type="bibr" rid="RSTB20180162C38">38</xref>]. The latter mRNAs are specifically targeted for polyadenylation by QKI-7 protein, which first binds the mRNAs and then recruits TENT2 to execute polyadenylation. Polyadenylation by TENT2 stabilizes mRNA and augments their translation.</p>
<p>Some further confirmed roles of TENT2 in mammals are in miRNA regulation. TENT2 is responsible for monoadenylation of certain mature miRNAs like a liver-specific <italic>miRNA-122</italic>, involved in the regulation of fatty acid homeostasis. The miRNA was found to be 3′ monoadenylated both in human hepatocytes and in mice livers [<xref ref-type="bibr" rid="RSTB20180162C39">39</xref>]. Since in <italic>TENT2</italic> knock-out mice the <italic>miRNA-122</italic> level is significantly lower than in wild-type mice, it has been suggested that monoadenylation of miRNA by TENT2 enhances its stability [<xref ref-type="bibr" rid="RSTB20180162C39">39</xref>]. In line with these findings is the observation that TENT2 depletion in human fibroblast cell line causes a significant reduction of a fraction of monoadenylated miRNAs [<xref ref-type="bibr" rid="RSTB20180162C40">40</xref>]. Furthermore, the stabilizing effect of monoadenylation on miRNA depends on the nucleotide composition within the miRNA 3′ region [<xref ref-type="bibr" rid="RSTB20180162C40">40</xref>]. TENT2 also acts as a poly(A) polymerase on miRNAs in mouse hippocampal neurons, but its deletion has no detectable effect on mice behaviour [<xref ref-type="bibr" rid="RSTB20180162C41">41</xref>].</p>
<p>There is a certain controversy regarding the involvement of TENT2 in the monouridylation and oligouridylation of pre-miRNA, especially of the so-called group II miRNA family including most of the <italic>let-7</italic> miRNAs. Essentially, TENT2 was suggested to participate in this process redundantly with two other confirmed human terminal uridyltransferases: TUT4 and TUT7 [<xref ref-type="bibr" rid="RSTB20180162C42">42</xref>,<xref ref-type="bibr" rid="RSTB20180162C43">43</xref>]. While TENT2 purified from human cells uridylated <italic>pre-let-7</italic> pre-miRNA [<xref ref-type="bibr" rid="RSTB20180162C42">42</xref>,<xref ref-type="bibr" rid="RSTB20180162C43">43</xref>], a recombinant protein purified from <italic>Escherichia coli</italic> showed superior specificity towards ATP in comparison to UTP with an enzymatic efficiency (<italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>m</sub>) roughly two orders of magnitude higher for ATP than for UTP [<xref ref-type="bibr" rid="RSTB20180162C44">44</xref>]. Interestingly, a single histidine insertion at position 440 of human TENT2 results in a switch from an ATP to a UTP preference of the protein [<xref ref-type="bibr" rid="RSTB20180162C44">44</xref>]. These data, together with a lack of solid evidence for an <italic>in vivo</italic> uridylating activity of TENT2, suggest that TENT2 is a <italic>bona fide</italic> ncPAP and not a TUTase.</p>
</sec>
<sec id="s2b">
<label>(b)</label>
<title>TENT4A, also known as LAK-1, PAPD7, POLK, POLS, TRF4 and TRF4-1</title>
<p>TENT4A is a human orthologue of the yeast Trf4p protein. Trf4p is a key subunit of the so-called TRAMP complex, within which it specifies mRNAs for surveillance and turnover by the nuclear exosome 3′–5′ ribonuclease complex [<xref ref-type="bibr" rid="RSTB20180162C45">45</xref>,<xref ref-type="bibr" rid="RSTB20180162C46">46</xref>], reviewed in [<xref ref-type="bibr" rid="RSTB20180162C47">47</xref>,<xref ref-type="bibr" rid="RSTB20180162C48">48</xref>]. However, TENT4A has not been identified as a component of the human TRAMP complex [<xref ref-type="bibr" rid="RSTB20180162C49">49</xref>].</p>
<p>TENT4A was shown to exist in two isoforms: TENT4A short (S) and TENT4A long (L). The latter possesses a longer N-terminal region and seems to be the predominant isoform in the cell [<xref ref-type="bibr" rid="RSTB20180162C50">50</xref>]. Although both isoforms contain a nucleotidyltransferase domain, only TENT4A L is able to add poly(A) tails when tethered to an RNA. TENT4A L is mainly localized in the nucleus but is excluded from the nucleolus. Interestingly, TENT4A S is evenly distributed throughout the cell, whereas only a small fraction of TENT4A L could be found in the cytoplasm. Further analysis revealed that the N-terminal region is crucial not only for nucleotidyltransferase activity but also for the nuclear localization of TENT4A L [<xref ref-type="bibr" rid="RSTB20180162C50">50</xref>]. In fact, on the basis of ribosome profiling [<xref ref-type="bibr" rid="RSTB20180162C51">51</xref>] and recent experimental work by Lim <italic>et al</italic>. [<xref ref-type="bibr" rid="RSTB20180162C52">52</xref>] it has been ascertained that TENT4A L possesses 20 amino acids more on its N-terminus than previously annotated [<xref ref-type="bibr" rid="RSTB20180162C50">50</xref>]. These, and an additional 10 N-terminal AAs show strong conservation with the N-terminus of another human Trf4p homologue—TENT4B [<xref ref-type="bibr" rid="RSTB20180162C52">52</xref>]. There are some suggestions that TENT4A may be involved in pre-mRNA maturation in the nucleoplasm, as TENT4A S was shown to interact with a non-nucleolar protein PRPF31, which is necessary for U4/U6-U5 tri-snRNP formation [<xref ref-type="bibr" rid="RSTB20180162C53">53</xref>]. Interestingly, TENT4B has also been reported to interact with a subset of splicing factors, among others with PRPF31 [<xref ref-type="bibr" rid="RSTB20180162C49">49</xref>]. Nevertheless, such a possibility would require further dedicated testing. Moreover, neither TENT4A nor TENT4B were pulled down with the purified, catalytic human spliceosomes [<xref ref-type="bibr" rid="RSTB20180162C54">54</xref>].</p>
<p>A recent report using a mammalian cell-free system based on HEK293F cell extracts suggests involvement of TENT4A in miRNP-mediated translational activation of non-adenylated mRNAs [<xref ref-type="bibr" rid="RSTB20180162C55">55</xref>]. Surprisingly, solely the presence of TENT4A, rather than its poly(A) polymerase activity, seems necessary for this activation. Also, overexpression of TENT4A in this system represses translation of polyadenylated mRNAs. This suggests that TENT4A may also function in a polyadenylation-independent manner. However, the TENT4A clone used by these authors lacked 10 of the 30 N-terminal amino acids reported as highly conserved [<xref ref-type="bibr" rid="RSTB20180162C52">52</xref>].</p>
</sec>
<sec id="s2c">
<label>(c)</label>
<title>TENT4B, also known as GLD4, PAPD5, TUT3 and TRF4-2</title>
<p>TENT4B is another human orthologue of the yeast Trf4p protein. Initially, TENT4B had been suggested to be involved in uridylation-mediated turnover of replication-dependent histone mRNAs in the cytoplasm [<xref ref-type="bibr" rid="RSTB20180162C56">56</xref>]. However, this result is controversial and has been challenged by other studies [<xref ref-type="bibr" rid="RSTB20180162C57">57</xref>,<xref ref-type="bibr" rid="RSTB20180162C58">58</xref>]. Essentially, human TENT4B has a strong preference for ATP incorporation (in the apparent preference order ATP ≫ GTP &gt; CTP ∼ UTP) with a variety of RNA substrates tested <italic>in vitro</italic>, ranging from oligo(A) and oligo(U) to different tRNAs as well as the 3′ UTR of histone mRNAs [<xref ref-type="bibr" rid="RSTB20180162C57">57</xref>]. Additionally, examination of TENT4B-EGFP-expressing cells, as well as immunofluorescence analysis, demonstrated its nuclear localization with nucleolar accumulation [<xref ref-type="bibr" rid="RSTB20180162C49">49</xref>,<xref ref-type="bibr" rid="RSTB20180162C57">57</xref>]. These findings suggest that TENT4B function in the mammalian nucleus may be similar to that of the TRAMP complex in yeast [<xref ref-type="bibr" rid="RSTB20180162C59">59</xref>]. Furthermore, and in contrast to yeast Trf4p which requires the Air2p zinc knuckle protein [<xref ref-type="bibr" rid="RSTB20180162C45">45</xref>,<xref ref-type="bibr" rid="RSTB20180162C60">60</xref>], human TENT4B does not require a protein cofactor for its polyadenylation activity, thus demonstrating its mechanistical distinction from its yeast counterpart [<xref ref-type="bibr" rid="RSTB20180162C57">57</xref>].</p>
<p>The analysis of RNAs UV cross-linked to TENT4B <italic>in vivo</italic> revealed that rRNAs are other potential substrates for TENT4B [<xref ref-type="bibr" rid="RSTB20180162C57">57</xref>]. In mice, TENT4B (but not TENT4A) is involved in the adenylation of aberrant precursor rRNA (pre-rRNA) fragments, leading to their degradation by the nuclear exosome [<xref ref-type="bibr" rid="RSTB20180162C61">61</xref>]. In line with this finding, TENT4B, ZCCHC7 (hAIR2) and SKIV2L2 (hMTR4) have been identified as components of the human TRAMP complex which, together with the nucleolar exosome possessing EXOSC10 (hRRP6) as a catalytic subunit, are involved in the turnover of pre-rRNA fragments in HeLa cells [<xref ref-type="bibr" rid="RSTB20180162C49">49</xref>,<xref ref-type="bibr" rid="RSTB20180162C62">62</xref>–<xref ref-type="bibr" rid="RSTB20180162C64">64</xref>]. Furthermore, proteomic analysis of TENT4B and ZCCHC7 revealed their interactions with components of the small subunit (SSU) processome, which is the first precursor of the small ribosomal subunit in Eukaryotes involved in the early steps of pre-rRNA processing in the nucleolus [<xref ref-type="bibr" rid="RSTB20180162C49">49</xref>,<xref ref-type="bibr" rid="RSTB20180162C50">50</xref>,<xref ref-type="bibr" rid="RSTB20180162C65">65</xref>], reviewed in [<xref ref-type="bibr" rid="RSTB20180162C66">66</xref>]. TENT4B, however, is also able to polyadenylate mature rRNAs. In mice, daily oscillations in liver mass arise from regulated changes in the number of ribosomes and their translational activity [<xref ref-type="bibr" rid="RSTB20180162C67">67</xref>]. Ribosomal protein synthesis is regulated in the phase opposite to the transcription of rRNAs. During daily rest/activity cycles, rRNAs synthesized in excess and not packaged into complete ribosomal subunits are polyadenylated by TENT4B and degraded by the nuclear exosome [<xref ref-type="bibr" rid="RSTB20180162C67">67</xref>].</p>
<p>TENT4B participates in the maturation of the H/ACA box snoRNAs (small nucleolar RNAs) by adding oligo(A) tails to the last nucleotides remaining after exonucleolytic degradation of the 3′ flanking intron. The oligo(A) tails, together with remaining intron nucleotides, are then removed by poly(A) specific ribonuclease (PARN) resulting in mature and stable snoRNAs [<xref ref-type="bibr" rid="RSTB20180162C68">68</xref>]. This effect is consistent with a proteomic analysis that detected both C/D box- and H/ACA box-specific proteins in a TENT4B immunoprecipitate [<xref ref-type="bibr" rid="RSTB20180162C49">49</xref>].</p>
<p>Previous studies have suggested that TENT4B (but not TENT4A) can mediate non-templated 3′ adenylation of some miRNAs in humans [<xref ref-type="bibr" rid="RSTB20180162C57">57</xref>,<xref ref-type="bibr" rid="RSTB20180162C69">69</xref>]. In particular, TENT4B-mediated adenylation of the 3′ end of <italic>miR-21-5p</italic> marks it for degradation by PARN. This degradation pathway is disrupted in a wide range of cancers and other proliferative diseases [<xref ref-type="bibr" rid="RSTB20180162C70">70</xref>]. The oncogenic role of <italic>miR-21-5p</italic> is owing to downregulation of various tumour suppressors. Interestingly, in HER2-amplified tumours <italic>miR-21-5p</italic> trimming is controlled by <italic>miR-4728-3p</italic>-mediated downregulation of TENT4B, leading to high steady-state levels of active <italic>miR-21-5p</italic> [<xref ref-type="bibr" rid="RSTB20180162C71">71</xref>]. These results suggest that TENT4B itself may be a tumour suppressor.</p>
<p>TENT4B plays an important role in the quality control pathway of human telomerase RNA (hTR) [<xref ref-type="bibr" rid="RSTB20180162C72">72</xref>]. Mutations in the hTR, the telomerase RNP component dyskerin (DKC1), and PARN can lead to insufficient telomerase activity leading to the <italic>dyskeratosis congenital</italic> (DC) disease. Compromised biding of dyskerin to hTR results in its adenylation by TENT4B, followed by EXOSC10-mediated 3′ to 5′ degradation, as well as decapping by DCP2 and 5′ to 3′ degradation by XRN1. On the other hand, under normal conditions PARN deadenylase competes with TENT4B and by removing oligo(A) tails prevents hTR degradation, maintaining its physiological concentration in equilibrium [<xref ref-type="bibr" rid="RSTB20180162C72">72</xref>].</p>
<p>A similar model of TENT4B–PARN competition and cooperation has been proposed for Y RNA maturation and degradation [<xref ref-type="bibr" rid="RSTB20180162C73">73</xref>]. Human Y RNAs are abundant small RNA polymerase III (Pol III)-transcribed RNAs with a role in RNA quality control, histone mRNA processing, DNA replication and damage response [<xref ref-type="bibr" rid="RSTB20180162C74">74</xref>]. Y RNAs mature in a process involving their adenylation by TENT4B and trimming by PARN and EXOSC10. In the absence of PARN or EXOSC10, the Y RNA possessing oligo(A) tails is degraded by cytoplasmic DIS3L or nuclear TOE1 3′–5′ exoribonucleases [<xref ref-type="bibr" rid="RSTB20180162C73">73</xref>,<xref ref-type="bibr" rid="RSTB20180162C75">75</xref>]. Low levels of Y RNAs intensify the effect of PARN depletion on telomere maintenance, leading to the severe phenotype of DC observed in patients carrying PARN mutations [<xref ref-type="bibr" rid="RSTB20180162C73">73</xref>].</p>
<p>Finally, TENT4B has been reported to act in a pathway affecting the tumour suppressor TP53 (also known as p53) [<xref ref-type="bibr" rid="RSTB20180162C76">76</xref>]. In this pathway, CPEB binds to the 3′ UTR of <italic>TP53</italic> mRNA and recruits TENT4B, which in a polyadenylation-dependent manner increases <italic>TP53</italic> mRNA stability and thus modulates its translational competence. In turn, the expression of CPEB is regulated by <italic>miR-122</italic>, whose supply depends on its stabilization by TENT2. This may be another piece of evidence of TENT4B acting as a tumour suppressor in human cells. In a recent report from the same laboratory hundreds of other mRNAs whose polyadenylation is regulated by TENT4B have been identified in a genome-wide screen [<xref ref-type="bibr" rid="RSTB20180162C77">77</xref>]. Several of these mRNAs are involved in carbohydrate metabolism. Depletion of TENT4B reduces <italic>GLUT1</italic> mRNA poly(A) tail length and the level of GLUT1 protein—a major glucose transporter. Similarly, as with <italic>TP53</italic>, TENT4B-mediated stabilization of <italic>GLUT1</italic> mRNA is dependent on CPEB. In addition to this, TENT4B regulates the poly(A) tails of several other mRNAs that are involved in carbohydrate metabolism, including <italic>G6PD</italic>, <italic>PFKFB3</italic>, <italic>PFK-1</italic>, <italic>GK</italic>, <italic>TALDO1</italic> and <italic>ENO1</italic>.</p>
</sec>
<sec id="s2d">
<label>(d)</label>
<title>TENT4A and TENT4B in mixed A/G tailing</title>
<p>Based on similarity, it was expected that TENT4A and TENT4B would at least partially functionally overlap, although their functions have mostly been studied separately so far (<xref ref-type="fig" rid="RSTB20180162F1">figure 1</xref>). A recent report proposed an interesting not previously described role of both TENT4A and TENT4B [<xref ref-type="bibr" rid="RSTB20180162C52">52</xref>]. These enzymes were implicated in polyadenylation of protein-coding mRNAs. However, owing to their slightly promiscuous nucleotide specificity, the enzymes occasionally incorporate GMP within the extended poly(A) tails [<xref ref-type="bibr" rid="RSTB20180162C52">52</xref>]. <xref ref-type="fig" rid="RSTB20180162F2">Figure 2</xref> depicts the process whereby following TENT4A/B activity, deadenylation of the poly(A) tails is executed by CNOT6 L and CNOT7 within the CNOT deadenylating complex. Deadenylation stops on guanine residues owing to the A-preference of CNOT6 L/7, which ultimately results in an increased frequency of guanine residues on the 3′ ends of mRNA with long poly(A) tails [<xref ref-type="bibr" rid="RSTB20180162C52">52</xref>]. The process is likely more complex owing to the involvement of other factors including poly(A) binding proteins (PABP) that also participate in the adenylation-deadenylation-driven regulation of poly(A) tails [<xref ref-type="bibr" rid="RSTB20180162C78">78</xref>–<xref ref-type="bibr" rid="RSTB20180162C80">80</xref>]. While not explicitly stated in the original study [<xref ref-type="bibr" rid="RSTB20180162C52">52</xref>], the mixed A/G tailing would likely occur in the nucleus given the nuclear localization of TENT4A and TENT4B [<xref ref-type="bibr" rid="RSTB20180162C49">49</xref>,<xref ref-type="bibr" rid="RSTB20180162C50">50</xref>,<xref ref-type="bibr" rid="RSTB20180162C57">57</xref>]. It is, however, also possible that small fractions of TENT4A/B present in the cytoplasm might also participate in mixed A/G tailing. The mechanism of substrate selection and the general impact of mixed A/G tailing by TENT4A and TENT4B on mRNA metabolism remain to be established. Finally, the importance of mixed A/G tailing in different cellular and tissue contexts and at the organismal levels also requires further experimental confirmation.
<fig id="RSTB20180162F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Mixed A/G tailing by TENT4A/B. RNA polymerase II transcribed mRNA is capped and polyadenylated. The poly(A) tail can be additionally tailed with GMP residues by TENT4A/B proteins. The mixed A/G tail (with 1 G incorporated per 10–20 As) is more resistant to the CNOT complex-mediated deadenylation than the pure poly(A) tail as both CNOT6 L and CNOT7 deadenylases fall off their substrates once they encounter a G (a non-A) residue. Ultimately all mRNAs are degraded from both 5′ and 3′ ends following deadenylation and decapping.</p></caption><graphic xlink:href="rstb20180162-g2"></graphic></fig></p>
</sec>
<sec id="s2e">
<label>(e)</label>
<title>TENT5 proteins</title>
<p>TENT5 comprises a group of four previously unrecognized evolutionarily conserved TENTs also known under the FAM46 acronym (FAMily with sequence similarity 46) in human and mice. These are TENT5A (FAM46A, other synonyms C6orf37, FJL20037), TENT5B (FAM46B, MGC16491), TENT5C (FAM46C, FJL20202) and TENT5D (FAM46D also known as CT1.26, CT112 and MGC26999) (<xref ref-type="fig" rid="RSTB20180162F1">figure 1</xref>). TENT5 proteins were initially discovered by an <italic>in silico</italic> study and described as putative poly(A) polymerases [<xref ref-type="bibr" rid="RSTB20180162C5">5</xref>]. All TENT5 homologues are highly similar in their amino acid sequences and share a common two-domain architecture with (i) an NTase domain distantly related to known NTase domains of other PAPs and TUTases, but comprising well conserved acidic amino acids in its putative catalytic centre and (ii) a poly(A) polymerase/2′–5′-oligoadenylate synthetase 1 substrate binding domain (PAP/OAS1 SBD) [<xref ref-type="bibr" rid="RSTB20180162C5">5</xref>,<xref ref-type="bibr" rid="RSTB20180162C81">81</xref>]. The latter is likely involved in substrate RNA binding and stabilization during poly(A) tail formation. Indeed, a recent study confirmed that human TENT5C and TENT5D form RNA–protein complexes and possess poly(A) polymerase activity that depends on the presence of acidic residues within the proteins' NTase domains [<xref ref-type="bibr" rid="RSTB20180162C82">82</xref>].</p>
<p>In stark contrast to the scarcity of studies describing TENT5 proteins' activity on a molecular level, there are plenty of reports linking mutations in TENT5 proteins to multiple less or more severe conditions.</p>
<p>TENT5A was first described as C6orf37 (Chromosome 6 open reading frame 37), a protein of unknown function with possible relation to human retinal diseases including <italic>retinitis pigmentosa</italic> [<xref ref-type="bibr" rid="RSTB20180162C83">83</xref>–<xref ref-type="bibr" rid="RSTB20180162C85">85</xref>]. Furthermore, TENT5A is highly expressed in ameloblast nuclei of tooth germs and may play a significant role in the formation of enamel [<xref ref-type="bibr" rid="RSTB20180162C86">86</xref>]. Moreover, it has been shown that polymorphism in the second exon of <italic>TENT5A</italic> may be associated with an increased risk of large-joint osteoarthritis [<xref ref-type="bibr" rid="RSTB20180162C87">87</xref>], which is consistent with severe skeletal abnormalities of <italic>TENT5A</italic> knock-out mice [<xref ref-type="bibr" rid="RSTB20180162C88">88</xref>]. Finally, loss-of-function mutations in <italic>TENT5A</italic> have been reported in patients suffering from severe, autosomal recessive forms of <italic>osteogenesis imperfecta</italic> [<xref ref-type="bibr" rid="RSTB20180162C89">89</xref>].</p>
<p>Much less is known about TENT5B. There is only a single report demonstrating upregulation of the protein in refractory <italic>lupus nephritis</italic> [<xref ref-type="bibr" rid="RSTB20180162C90">90</xref>].</p>
<p>TENT5C is one of the most frequently mutated genes in a B-cell malignancy—multiple myeloma (MM)—following well-known proto-oncogenes of the RAS family [<xref ref-type="bibr" rid="RSTB20180162C91">91</xref>]. It has been shown, using whole-genome and whole-exome sequencing, that homozygotic or hemizygotic mutations of <italic>TENT5C</italic> are found in 3.4–13% of primary MM cases [<xref ref-type="bibr" rid="RSTB20180162C91">91</xref>–<xref ref-type="bibr" rid="RSTB20180162C93">93</xref>]. To date, over 70 different mutations have been identified, most of them frameshift or nonsense mutations [<xref ref-type="bibr" rid="RSTB20180162C94">94</xref>]. Moreover, deletion of cytoband 1p12, where the <italic>TENT5C</italic> gene is located, was found in about 20% of MM patients and loss of <italic>TENT5C</italic> is associated with limited survival [<xref ref-type="bibr" rid="RSTB20180162C92">92</xref>]. In a recent study, several MM cell lines bearing <italic>TENT5C</italic> mutations showed significantly reduced growth and lower survival rates of these cells upon expression of wild-type TENT5C [<xref ref-type="bibr" rid="RSTB20180162C82">82</xref>]. Furthermore, knock-down of TENT5C enhanced proliferation rates of B lymphocytes, thus showing the role of TENT5C in generally suppressing cell growth. Thus, TENT5C likely acts as an onco-suppressor by the specific and robust polyadenylation of a subset of mRNAs mostly encoding endoplasmic reticulum-targeted and secreted proteins [<xref ref-type="bibr" rid="RSTB20180162C82">82</xref>]. Nevertheless, the specificity mechanism remains unknown. In another study, TENT5C overexpression caused downregulation of transcriptional factors IRF4, CEBPB and MYC, and upregulation of immunoglobulin light chain [<xref ref-type="bibr" rid="RSTB20180162C95">95</xref>]. Therefore, the effect of mutations of <italic>TENT5C</italic> in MM pathogenesis seems to be caused by the misregulation of the endoplasmic reticulum homeostasis [<xref ref-type="bibr" rid="RSTB20180162C82">82</xref>,<xref ref-type="bibr" rid="RSTB20180162C95">95</xref>]. In contrast to some earlier claims of TENT5C being an essential gene whose deficiency would cause embryolethality [<xref ref-type="bibr" rid="RSTB20180162C96">96</xref>], an independent study demonstrated a lack of major phenotypes in <italic>TENT5C</italic> knock-out mice [<xref ref-type="bibr" rid="RSTB20180162C82">82</xref>]. Instead, the mice suffered from anaemia likely owing to an abnormality in haemoglobin synthesis that might be connected to TENT5C activity as a growth regulator in the blood cells' B-lineage [<xref ref-type="bibr" rid="RSTB20180162C82">82</xref>]. Besides MM, the <italic>TENT5C</italic> gene is suggested to play a role in the pathogenesis of other tumours [<xref ref-type="bibr" rid="RSTB20180162C97">97</xref>–<xref ref-type="bibr" rid="RSTB20180162C99">99</xref>]. <italic>TENT5C</italic> expression is significantly lower in hepatocellular carcinoma than in normal liver tissue [<xref ref-type="bibr" rid="RSTB20180162C99">99</xref>]. Moreover, <italic>TENT5C</italic> is upregulated in response to norcantharidin (an antimetastatic drug used in hepatocellular carcinoma). Upregulation of <italic>TENT5C</italic> causes reduction of cancer cell migration and invasion [<xref ref-type="bibr" rid="RSTB20180162C98">98</xref>]. A similar effect is observed in gastric cancer—in cancerous tissues, a significant reduction of <italic>TENT5C</italic> levels is observed. Low <italic>TENT5C</italic> levels are associated with higher risk of recurrence after gastric resection and generally poor prognosis [<xref ref-type="bibr" rid="RSTB20180162C97">97</xref>]. Finally, mutations in <italic>TENT5C</italic> also appear to be related to autism [<xref ref-type="bibr" rid="RSTB20180162C100">100</xref>].</p>
<p>TENT5D dysfunction might also be related to autism as TENT5D is overexpressed in the cerebral cortex of mice with autism-like behaviours [<xref ref-type="bibr" rid="RSTB20180162C100">100</xref>]. Finally, in humans, antibodies against TENT5D are present exclusively in the serum of patients suffering from testis and lung tumours [<xref ref-type="bibr" rid="RSTB20180162C101">101</xref>].</p>
</sec>
<sec id="s2f">
<label>(f)</label>
<title>MTPAP, also known as FLJ10486, mtPAP, PAPD1, SPAX4 and TENT6</title>
<p>MTPAP is unique among all the other TENTs as it is localized exclusively in mitochondria and is the only known ncPAP known to polyadenylate mitochondrial RNAs [<xref ref-type="bibr" rid="RSTB20180162C102">102</xref>,<xref ref-type="bibr" rid="RSTB20180162C103">103</xref>]. <italic>In vitro</italic>, MTPAP can use all four nucleotides as substrates, although the strongest activity is observed with both ATP and UTP [<xref ref-type="bibr" rid="RSTB20180162C104">104</xref>]. Interestingly, structural and biochemical analysis suggests that the enzyme is active only as a dimer [<xref ref-type="bibr" rid="RSTB20180162C104">104</xref>]. MTPAP does not seem to rely on RNA-binding proteins for substrate recognition, but some proteins could enhance its activity. For instance, LRPPRC/SLIRP, a mitochondrial RNA-binding complex, enhances the polyadenylation of mitochondrial mRNAs (mt-mRNAs) by MTPAP <italic>in vitro</italic> [<xref ref-type="bibr" rid="RSTB20180162C105">105</xref>,<xref ref-type="bibr" rid="RSTB20180162C106">106</xref>]. Furthermore, MTPAP might interact with a complex formed by mitochondrial RNA helicase SUV3 and exoribonuclease PNPase to regulate the length of mt-mRNA 3′ poly(A) depending on the inorganic Pi/ATP ratios and so in response to cellular energy changes [<xref ref-type="bibr" rid="RSTB20180162C107">107</xref>]. In contrast to cellular cytoplasmic mRNAs, the poly(A) tails in mt-mRNAs serve different functions. In mammalian mitochondria, a majority of the mtDNA-encoded mRNAs (in humans 7 out of 13) have incomplete stop codons represented only by the U or UA. MTPAP adds AMP residues to the 3′ end of mt-mRNAs forming an oligo- or poly(A) tail and simultaneously generating the proper UAA stop codon (reviewed in [<xref ref-type="bibr" rid="RSTB20180162C108">108</xref>–<xref ref-type="bibr" rid="RSTB20180162C110">110</xref>]). MTPAP also plays an important role in the maturation of mt-tRNAs. In human mitochondria the genes coding for tRNA Tyr and tRNA Cys overlap by one nucleotide, which results in an incomplete tRNA Tyr precursor lacking the 3′-terminal adenosine. This precursor is a substrate for MTPAP, which may add one or more AMPs to its 3′ end. If only one AMP is added, the tRNA Tyr precursor becomes a substrate for CCA addition and further acetylation. In case of MTPAP adding an oligo(A) tail, either the 3′–5′ deadenylase PDE12 or the endonuclease RNase Z removes the excessive nucleotides, producing a substrate for CCA addition [<xref ref-type="bibr" rid="RSTB20180162C111">111</xref>,<xref ref-type="bibr" rid="RSTB20180162C112">112</xref>].</p>
<p>The role of mitochondrial polyadenylation in RNA stability, turnover and translation remains an open question and is discussed elsewhere [<xref ref-type="bibr" rid="RSTB20180162C108">108</xref>–<xref ref-type="bibr" rid="RSTB20180162C110">110</xref>]. In two different studies, it has been observed that the silencing of MTPAP leads to the shortening of mt-mRNAs' poly(A) tails [<xref ref-type="bibr" rid="RSTB20180162C102">102</xref>,<xref ref-type="bibr" rid="RSTB20180162C103">103</xref>]. However, in one of these reports no changes in a steady state level of mt-mRNAs or their protein products have been observed [<xref ref-type="bibr" rid="RSTB20180162C103">103</xref>], whereas according to another study, knock-down of MTPAP decreases the stability of the <italic>CO1</italic>, <italic>CO2</italic>, <italic>CO3</italic> and <italic>ATP6</italic> mRNAs, but has no effect on the <italic>ND3</italic> mRNA [<xref ref-type="bibr" rid="RSTB20180162C102">102</xref>]. Interestingly, a homozygous N478D mutation in MTPAP also results in shorter poly(A) tails for all mt-mRNA transcripts tested, but its effect on stability is transcript-dependent [<xref ref-type="bibr" rid="RSTB20180162C106">106</xref>].</p>
<p>Two other functions have been proposed for MTPAP. First, it has been suggested to oligouridylate histone mRNAs, inducing their degradation [<xref ref-type="bibr" rid="RSTB20180162C56">56</xref>]. Another study proposed that MTPAP may be involved in adenylation of some miRNAs [<xref ref-type="bibr" rid="RSTB20180162C113">113</xref>]. However, since MTPAP is an exclusively mitochondrial protein, these functions are controversial.</p>
<p>There are reports linking mutations in <italic>MTPAP</italic> to some genetic disorders. Mutation N478D in the so-called fingers domain within a very conserved region of the protein is associated with an autosomal-recessive disease—spastic ataxia with optic atrophy [<xref ref-type="bibr" rid="RSTB20180162C114">114</xref>]. In this condition the poly(A) tails of mt-mRNAs are significantly shorter in all homozygous individuals as compared to hemizygous carriers and healthy individuals [<xref ref-type="bibr" rid="RSTB20180162C106">106</xref>,<xref ref-type="bibr" rid="RSTB20180162C114">114</xref>]. Further work established that the homozygous N478D mutation also causes cellular radiosensitivity and persistent DNA double-strand breaks [<xref ref-type="bibr" rid="RSTB20180162C115">115</xref>]. Another mutation in <italic>MTPAP</italic>, D39G, was found to be associated with extreme obesity in cattle [<xref ref-type="bibr" rid="RSTB20180162C116">116</xref>]. Molecular mechanisms leading to the observed disorders remain elusive.</p>
</sec>
</sec>
<sec id="s3">
<label>3.</label>
<title>TUTases and uridylation</title>
<p>Uridylation is a common phenomenon reported for the majority of RNA species in a mammalian cell. In this process one to 20+ uridines are appended to the RNA 3′ end by either of three confirmed TUTases: TENT1 (U6 TUTase), TUT4 or TUT7. While TENT1 is a nuclear enzyme, TUT4 and TUT7 localize in the cytoplasm, which in turn defines their substrate RNAs. In general, in mammals, uridylation has been linked with the biogenesis of certain RNAs and with reduced stability of the uridylated RNAs. Here we describe the major findings with each of the TUTases, the differential impact of uridylation on different RNA classes and the global role of uridylation in mammals, concluding with the newest findings. See also reviews in this issue by Zigackova and Vanacova [<xref ref-type="bibr" rid="RSTB20180162C117">117</xref>] and De Almeida <italic>et al</italic>. [<xref ref-type="bibr" rid="RSTB20180162C118">118</xref>] on uridylation in other organisms.</p>
<sec id="s3a">
<label>(a)</label>
<title>TENT1, also known as RBM21, TUT1 and U6 TUTase</title>
<p>TENT1 is a protein highly evolutionarily conserved among vertebrates. It is widely expressed in all human tissues and a decrease in its level in cell lines leads to reduced proliferation rates and viability [<xref ref-type="bibr" rid="RSTB20180162C119">119</xref>,<xref ref-type="bibr" rid="RSTB20180162C120">120</xref>]. In line with this, most high-throughput genome-scale RNAi or CRISPR-based screens identified <italic>TENT1</italic> as an essential fitness gene [<xref ref-type="bibr" rid="RSTB20180162C121">121</xref>–<xref ref-type="bibr" rid="RSTB20180162C124">124</xref>]. TENT1 is dominantly localized in the nucleoplasm and nuclear speckle body-like structures and/or nucleolus [<xref ref-type="bibr" rid="RSTB20180162C125">125</xref>,<xref ref-type="bibr" rid="RSTB20180162C126">126</xref>]. Its localization in the nucleolus depends on an interaction with the NMP1 nucleolar protein and is reduced by ubiquitination by the Cullin-RING ubiquitin ligase complex subunit—KLHL7 protein [<xref ref-type="bibr" rid="RSTB20180162C125">125</xref>]. TENT1 comprises several domains, whose organization is different from TUT4 and TUT7 (<xref ref-type="fig" rid="RSTB20180162F1">figure 1</xref>) [<xref ref-type="bibr" rid="RSTB20180162C127">127</xref>,<xref ref-type="bibr" rid="RSTB20180162C128">128</xref>]. Starting from the N-terminus, TENT1 contains: a putative zinc finger (ZF) domain, an RNA recognition motif (RRM), a so-called ‘palm’ with a proline-rich region (PRR) insertion, so-called ‘fingers’ and a kinase associated-1 (KA-1) RNA-binding domain and a nuclear localization signal (NLS) [<xref ref-type="bibr" rid="RSTB20180162C128">128</xref>]. The ZF, RRM and KA-1 domains bind RNA, thus the protein likely does not require additional protein cofactors for RNA binding [<xref ref-type="bibr" rid="RSTB20180162C128">128</xref>,<xref ref-type="bibr" rid="RSTB20180162C129">129</xref>]. The mechanistic model deduced from the TENT1 crystal structure implies that the enzyme, by open-to-close state transitions, adds several UMPs to the RNA's 3′ end, which becomes compressed within the enzyme's active pocket. Once the RNA can no longer translocate to the active site it dissociates [<xref ref-type="bibr" rid="RSTB20180162C128">128</xref>]. The PRR region splits the PAP domain and can be phosphorylated by casein kinase I (CKI) isoforms α and ɛ, which modulates the enzyme's activity [<xref ref-type="bibr" rid="RSTB20180162C130">130</xref>]. Besides RNA binding, the KA-1 domain can also bind phospholipids, and so it might play a role in the postulated PtdIns-4,5(phosphatidylinositol-4,5-bisphosphate)-P2-dependent activation of TENT1, as described below [<xref ref-type="bibr" rid="RSTB20180162C128">128</xref>].</p>
<sec id="s3a1">
<label>(i)</label>
<title>TENT1 in U6 small nuclear RNA (snRNA) biogenesis</title>
<p>TENT1 was first discovered as an enzyme crucial in biogenesis of U6 snRNA responsible for the catalysis of pre-mRNA splicing [<xref ref-type="bibr" rid="RSTB20180162C117">117</xref>,<xref ref-type="bibr" rid="RSTB20180162C131">131</xref>–<xref ref-type="bibr" rid="RSTB20180162C133">133</xref>]. The nascent U6 snRNA transcript contains a tract of four uridines (Us) at the 3′ end that serves as a termination signal for Pol III [<xref ref-type="bibr" rid="RSTB20180162C134">134</xref>]. To become functional, U6 snRNA requires further post-transcriptional 3′ end maturation involving two opposite activities: oligouridylation carried out by TENT1 [<xref ref-type="bibr" rid="RSTB20180162C117">117</xref>,<xref ref-type="bibr" rid="RSTB20180162C131">131</xref>–<xref ref-type="bibr" rid="RSTB20180162C133">133</xref>] and subsequent exonucleolytic trimming executed by the USB1 protein, whose activity additionally leads to formation of a 2′–3′ cyclic phosphate at the 3′ end—a hallmark of U6 snRNA [<xref ref-type="bibr" rid="RSTB20180162C135">135</xref>–<xref ref-type="bibr" rid="RSTB20180162C139">139</xref>]. As a result, the majority of mature human U6 snRNAs contain five terminal uridines and a 2′–3′ cyclic phosphate moiety that protects them from oligouridylation-mediated destabilization [<xref ref-type="bibr" rid="RSTB20180162C118">118</xref>,<xref ref-type="bibr" rid="RSTB20180162C134">134</xref>,<xref ref-type="bibr" rid="RSTB20180162C140">140</xref>]. The presence of the terminal U-rich stretch is also crucial for U6 snRNA function in pre-mRNA splicing. Briefly, the uridine-rich 3′ tail constitutes a binding platform for the heteroheptameric Lsm2-8 protein complex that, cooperatively with the Prp24p protein, facilitates the annealing of U6 and U4 snRNAs during U4/U6 di-snRNP formation, as shown for the yeast U6 snRNP [<xref ref-type="bibr" rid="RSTB20180162C141">141</xref>–<xref ref-type="bibr" rid="RSTB20180162C144">144</xref>]. Thus, TENT1 contributes to increased stability of U6 snRNA molecules and indirectly to pre-mRNA splicing regulation.</p>
</sec>
<sec id="s3a2">
<label>(ii)</label>
<title>TENT1 as an adenyltransferase. The Star-PAP</title>
<p>There is some controversy regarding the role of TENT1 in nuclear adenylation of mRNAs in response to stress conditions. A decade ago TENT1 was reported as a highly processive nuclear speckle-targeted and PtdIns4,5P2-regulated nuclear poly(A) polymerase (Star-PAP) <italic>in vitro</italic> [<xref ref-type="bibr" rid="RSTB20180162C126">126</xref>,<xref ref-type="bibr" rid="RSTB20180162C145">145</xref>,<xref ref-type="bibr" rid="RSTB20180162C146">146</xref>]. It was suggested that TENT1 serves as a biosensor for the transduction of stress signals within the cell nucleus through targeting mRNAs involved in oxidative stress response (<italic>HO-1</italic> and <italic>NQO-1</italic>) and mRNA of a pro-apoptotic gene <italic>Bcl-2 interacting killer</italic> (<italic>BIK</italic>) [<xref ref-type="bibr" rid="RSTB20180162C126">126</xref>,<xref ref-type="bibr" rid="RSTB20180162C145">145</xref>,<xref ref-type="bibr" rid="RSTB20180162C146">146</xref>]. It was postulated that TENT1 interacts with CPSF-73, CPSF-160 of the Cleavage and Polyadenylation Specificity Factor and several other proteins, leading to the formation of poly(A) tails, instead of the canonical poly(A) formation pathway employing PAPα/γ, and thus specifically regulating the supply of selected mRNAs [<xref ref-type="bibr" rid="RSTB20180162C126">126</xref>,<xref ref-type="bibr" rid="RSTB20180162C129">129</xref>,<xref ref-type="bibr" rid="RSTB20180162C147">147</xref>,<xref ref-type="bibr" rid="RSTB20180162C148">148</xref>]. However, recent structural studies of nucleotide recognition by TENT1 revealed a superior coordination of the uracil base by hydrogen bonding with two conserved Asn and His residues and some stacking interactions within the enzyme's nucleotide binding pocket, while ATP is stabilized by just a single hydrogen bond [<xref ref-type="bibr" rid="RSTB20180162C128">128</xref>]. The arrangement of core TENT1 domains is topologically homologous to the yeast Cid1 uridyltransferase (but also to the human MTPAP). In line with this, biochemical <italic>in vitro</italic> activity assays showed that TENT1-mediated uridylation of U6 snRNA-u4 and <italic>3′-UTR-HO1</italic> transcripts is tens of times more efficient than adenylation [<xref ref-type="bibr" rid="RSTB20180162C128">128</xref>], which is in disagreement with a previous report showing higher ATP specificity of TENT1 in <italic>in vitro</italic> extension of <italic>A15</italic> and <italic>A44</italic> oligonucleotides [<xref ref-type="bibr" rid="RSTB20180162C126">126</xref>]. Nevertheless, the substrates used in the two experimental set-ups were significantly different, i.e. poly(A) RNAs in [<xref ref-type="bibr" rid="RSTB20180162C126">126</xref>] and <italic>HO-1</italic> 3′ UTR without 3′ adenines in [<xref ref-type="bibr" rid="RSTB20180162C128">128</xref>], which might have influenced the observed preferences. Given the highly complex nature of the 3′ end regulatory networks (<xref ref-type="fig" rid="RSTB20180162F2">figure 2</xref>) it also cannot be ruled out that TENT1 activity changes <italic>in vivo</italic> owing to its allosteric or structural transitions under specific physiological conditions, such as oxidative stress, or through specific interacting proteins. Interestingly, TENT1 interacts also with nuclear PIPKIα and PKCδ kinases, which by phosphorylation might change its substrate preference from UTP to ATP [<xref ref-type="bibr" rid="RSTB20180162C126">126</xref>,<xref ref-type="bibr" rid="RSTB20180162C146">146</xref>,<xref ref-type="bibr" rid="RSTB20180162C147">147</xref>]. Finally, some recent reports also indicate that TENT1 interacts with both the Perlman syndrome 3′–5′ exoribonuclease DIS3L2 and Argonaute2 in an RNA-dependent manner, contributing to the regulation of miRNA abundance by uridylating RISC-bound miRNAs and inducing their degradation [<xref ref-type="bibr" rid="RSTB20180162C113">113</xref>,<xref ref-type="bibr" rid="RSTB20180162C149">149</xref>–<xref ref-type="bibr" rid="RSTB20180162C151">151</xref>]. This process would likely happen in the cytoplasm and thus it constitutes another controversy regarding TENT1.</p>
</sec>
</sec>
<sec id="s3b">
<label>(b)</label>
<title>TUTases (TUT4 and TUT7) in cytoplasmic RNA uridylation</title>
<p>TUT4 (also known as KIAA0191, PAPD3, TENT3A and ZCCHC11) and TUT7 (also known as FLJ13409, KIAA1711, PAPD6, TEBT3B and ZCCHC6) share significant sequence similarities and TUT7 is thought to have evolved as a result of TUT4 duplication [<xref ref-type="bibr" rid="RSTB20180162C152">152</xref>]. Both TUT4 and TUT7 are large proteins (in human approximately 185 and 171 kDa, respectively) and comprise catalytic ribonucleotidyltransferase domains with a conserved DDD triad in their catalytic centres and, interestingly, non-catalytic NTr-like domains lacking critical catalytic aspartate residues (<xref ref-type="fig" rid="RSTB20180162F1">figure 1</xref>). Important are four zinc finger/knuckle domains of C2H2 (one, ZF) and CCHC (three, ZK) types scattered within the proteins' bodies. The ZF and ZKs might act as protein–RNA and protein–protein interaction platforms. Indeed, the first of these motifs from the protein's N-terminus (ZF) has been demonstrated to interact with the LIN28a protein [<xref ref-type="bibr" rid="RSTB20180162C127">127</xref>,<xref ref-type="bibr" rid="RSTB20180162C153">153</xref>] and the third has been shown to be involved in the stabilization of the growing oligouridine tail during uridylation of the pre-let-7 miRNA precursors [<xref ref-type="bibr" rid="RSTB20180162C127">127</xref>]. TUT4 comprises two additional domains—one on its N-terminus and one on its C-terminus. These domains seem irrelevant for uridyltrasferase activity but might play some other yet undiscovered roles [<xref ref-type="bibr" rid="RSTB20180162C127">127</xref>,<xref ref-type="bibr" rid="RSTB20180162C153">153</xref>]. Most reports suggest redundant functions of TUT4 and TUT7, however, depending on cellular model or tissue context, these enzymes might also perform different functions.</p>
<sec id="s3b1">
<label>(i)</label>
<title>Oligo- and monouridylation in pre-miRNA regulation—a double faceted effect of TUTases</title>
<p>Initially, TUTases were characterized for their role in uridylating precursors of the <italic>let-7</italic> miRNA family. These miRNAs are involved in cell differentiation and deregulated in cancer development (reviewed in [<xref ref-type="bibr" rid="RSTB20180162C154">154</xref>,<xref ref-type="bibr" rid="RSTB20180162C155">155</xref>]). In non-differentiated cells the LIN28a protein is expressed. It specifically binds miRNA precursors and a TUTase, promoting processive oligouridylation of the precursor miRNA, which ultimately precludes its processing by DICER and leads to degradation of the oligouridylated <italic>pre-let-7</italic> [<xref ref-type="bibr" rid="RSTB20180162C156">156</xref>–<xref ref-type="bibr" rid="RSTB20180162C163">163</xref>]. In contrast to that, in differentiated cells LIN28a is not expressed [<xref ref-type="bibr" rid="RSTB20180162C42">42</xref>,<xref ref-type="bibr" rid="RSTB20180162C164">164</xref>]. In its absence, TUT4/7 add prevalently just a single uridine to the 3′ end of the <italic>pre-let-7</italic> RNAs. In fact, miRNA precursors fall into two families regarding their 3′ end: it is either a 2-nucleotide 3′ overhang (group I of prototypical pre-miRNA) or just a single nucleotide 3′ overhang (group II). Since DICER requires a 2-nucleotide 3′ overhang for processing of the pre-miRNA into mature miRNA, group II pre-miRNA comprising a majority of <italic>let-7</italic> family RNAs cannot be processed [<xref ref-type="bibr" rid="RSTB20180162C42">42</xref>]. However, once monouridylated, the group II pre-miRNAs are conveyed to the later steps of their maturation [<xref ref-type="bibr" rid="RSTB20180162C42">42</xref>,<xref ref-type="bibr" rid="RSTB20180162C43">43</xref>]. Thus, a single protein LIN28a provides a crucial discriminatory mechanism for either oligo- or monouridylation and their respective effects in blocking or promoting microRNA maturation. Small molecules inhibiting LIN28a-<italic>pre-let-7</italic> interactions have recently been published providing a foundation for the treatment of LIN28a-induced disorders, mainly different cancers ([<xref ref-type="bibr" rid="RSTB20180162C165">165</xref>] and references therein).</p>
<p>Apart from LIN28a, another protein—TRIM25—has been implicated in pre-miRNA oligouridylation [<xref ref-type="bibr" rid="RSTB20180162C164">164</xref>]. TRIM25 might act as a <italic>pre-let-7</italic>-specific activator of LIN28a/TUT4-mediated uridylation. In mammals also mature miRNAs are globally and/or specifically uridylated under a variety of conditions including normal growth, differentiation, in response to either dynamic environmental changes, accompanying viral infection or in maintenance of steady-state naive T cells [<xref ref-type="bibr" rid="RSTB20180162C113">113</xref>,<xref ref-type="bibr" rid="RSTB20180162C149">149</xref>,<xref ref-type="bibr" rid="RSTB20180162C166">166</xref>–<xref ref-type="bibr" rid="RSTB20180162C170">170</xref>]. As a result of uridylation miRNAs might lose their regulatory potential and are destined for degradation.</p>
<p>Experimental evidence gathered so far and recent structural information on the pre-miRNA-LIN28a-TUT4 ternary complex revealed a processivity mechanism for uridylation wherein all components of the ternary complex contribute to stabilization of the TUTase-RNA interactions [<xref ref-type="bibr" rid="RSTB20180162C127">127</xref>,<xref ref-type="bibr" rid="RSTB20180162C171">171</xref>]. Furthermore, once a few uridines are appended, the ZK 2 domain in the TUTase engages the growing oligo(U) tail in U-specific interactions that altogether assure enough stability for further processive oligo(U) addition by the TUTase [<xref ref-type="bibr" rid="RSTB20180162C127">127</xref>]. The structure also suggests the way in which the TUTase discriminates between group I and group II pre-miRNA, which relies on specific binding of group II miRNA precursors to the enzyme in a pre-catalytic state. Once monoU has been added, the newly formed 2-nucleotide overhang positions the RNA in a post-catalytic state reinforcing RNA dissociation. A similar non-favourable positioning in the post-catalytic state accounts for a lack of extension on the group I miRNA precursors in the absence of LIN28a [<xref ref-type="bibr" rid="RSTB20180162C127">127</xref>]. In the absence of LIN28a TUT4/7 uridylate exposed 3′ ends in a distributive manner without the need for a protein cofactor [<xref ref-type="bibr" rid="RSTB20180162C43">43</xref>,<xref ref-type="bibr" rid="RSTB20180162C172">172</xref>].</p>
</sec>
<sec id="s3b2">
<label>(ii)</label>
<title>Uridylation in replication-dependent histone mRNA clearance</title>
<p>It is currently acknowledged that TUT7 and to a lesser extend TUT4 are responsible for uridylating histone mRNAs [<xref ref-type="bibr" rid="RSTB20180162C57">57</xref>,<xref ref-type="bibr" rid="RSTB20180162C58">58</xref>,<xref ref-type="bibr" rid="RSTB20180162C173">173</xref>]. Histone mRNAs form a distinctive group of mammalian mRNAs, since they possess a stabilizing 3′ stem-loop instead of a poly(A) tail [<xref ref-type="bibr" rid="RSTB20180162C174">174</xref>,<xref ref-type="bibr" rid="RSTB20180162C175">175</xref>]. The availability of histone mRNAs in a cell is tightly regulated so that their expression keeps pace with DNA replication in the S phase. The tight regulation is important since if expressed in other cell growth phases histones interfere with several cellular processes leading to severe cytotoxicity [<xref ref-type="bibr" rid="RSTB20180162C176">176</xref>]. The tight regulation takes place both on transcriptional and post-transcriptional levels to ensure histone supply at the onset of S phase and their rapid clearance once replication is completed. In mammals, transcription of histone mRNAs changes 5–6 fold during cell cycle [<xref ref-type="bibr" rid="RSTB20180162C177">177</xref>,<xref ref-type="bibr" rid="RSTB20180162C178">178</xref>], thus the pivotal role in regulation of histone mRNA supply is their uridylation-dependent clearance [<xref ref-type="bibr" rid="RSTB20180162C56">56</xref>]. For details on histone mRNA regulation see a comprehensive review by Marzluff &amp; Koreski [<xref ref-type="bibr" rid="RSTB20180162C179">179</xref>] and a review by Stacie <italic>et al</italic>. [<xref ref-type="bibr" rid="RSTB20180162C180">180</xref>].</p>
</sec>
<sec id="s3b3">
<label>(iii)</label>
<title>mRNAs—general importance of uridylation in apoptosis, oocyte and embryo development</title>
<p>With the development of TAIL-Seq, a tool for global 3′ terminome analysis [<xref ref-type="bibr" rid="RSTB20180162C181">181</xref>], it became apparent that not only replication-dependent histone mRNAs but also mRNAs acquiring poly(A) tails are uridylated, though to different extents and depending on their poly(A) tail lengths. While for some mRNA species nearly 50% possessed 3′ non-templated uridines, for some others only a minor fraction (less than 2%) were uridylated [<xref ref-type="bibr" rid="RSTB20180162C182">182</xref>]. This discrepancy might have resulted from either specific uridylation or less effective degradation of some mRNAs, but the mechanistic explanation of either possibility requires further testing. In general, uridylation occurs frequently with mRNAs possessing short poly(A) tails of less than 20 As [<xref ref-type="bibr" rid="RSTB20180162C182">182</xref>]. Uridylation levels correlate with decreased mRNA stabilities [<xref ref-type="bibr" rid="RSTB20180162C182">182</xref>] that at least partially result from removal of uridylated mRNAs by the DIS3L2 3′–5′ exoribonuclease [<xref ref-type="bibr" rid="RSTB20180162C140">140</xref>,<xref ref-type="bibr" rid="RSTB20180162C180">180</xref>]. Uridylated RNAs are also likely removed by the 5′–3′ decay, since uridylation induced decapping, as shown in studies with uridylated reporter RNAs in human cellular extracts [<xref ref-type="bibr" rid="RSTB20180162C184">184</xref>]. It is likely that similarly to the situation in fission yeast, uridylated RNAs are bound by LSM1-7, decapped by the decapping complex (involving several protein components; see [<xref ref-type="bibr" rid="RSTB20180162C185">185</xref>] for a review) and degraded by the XRN1 5′–3′ exoribonuclease [<xref ref-type="bibr" rid="RSTB20180162C186">186</xref>]. Furthermore, abortive initiation of mRNA transcription by Pol II leads to the production of so-called transcriptional start-site-associated RNAs—TSSs. These are pervasively oligouridylated and undergo uridylation-dependent clearance by DIS3L2 [<xref ref-type="bibr" rid="RSTB20180162C187">187</xref>,<xref ref-type="bibr" rid="RSTB20180162C188">188</xref>].</p>
<p>There is no doubt that uridylation is common in mammalian cells. However, how essential is the modification? Is uridylation just a fine-tuning mechanism in RNA decay that if missing can be replaced by other pathways, or does uridylation play an indispensable role and, if so, is it spatially or temporarily restricted? A study by Thomas <italic>et al</italic>. [<xref ref-type="bibr" rid="RSTB20180162C189">189</xref>] highlighted the global importance of uridylation in apoptosis. Apoptosis is a complex process involving multiple regulatory mechanisms that occur in a step-wise manner. On the level of RNA, initial apoptotic mitochondrial outer membrane permeabilisation (MOMP) induces a global degradation of translation-competent mRNAs but not of non-coding RNAs at the onset of apoptosis [<xref ref-type="bibr" rid="RSTB20180162C189">189</xref>,<xref ref-type="bibr" rid="RSTB20180162C190">190</xref>]. The global mRNA decay is induced by TUT4/7-mediated uridylation and executed by DIS3L2 3′–5′ exoribonuclease [<xref ref-type="bibr" rid="RSTB20180162C189">189</xref>]. Simultaneously, pre-mRNA splicing and RNA nuclear export are inhibited, which prevents the production of stress-responsive factors [<xref ref-type="bibr" rid="RSTB20180162C191">191</xref>] and precedes phosphatidylserine externalization and DNA fragmentation. In fact, knock-down of TUTases or DIS3L2 leads to anti-apoptotic effects and increases survival of cells exposed to apoptotic stimuli [<xref ref-type="bibr" rid="RSTB20180162C180">180</xref>,<xref ref-type="bibr" rid="RSTB20180162C189">189</xref>].</p>
<p>Recent evidence identifies another crucial role of TUTases and uridylation in gametogenesis and early development. These results come from a study with TUT4/7 conditional knock-out (cKO) mice that demonstrated that TUTases are dispensable in adult animals since their lack does not lead to global transcriptome changes in somatic cells [<xref ref-type="bibr" rid="RSTB20180162C35">35</xref>]. Instead, the TUT4/7-mediated uridylation regulates the maternal protein-coding transcriptome in developing oocytes and is indispensable to complete meiosis I and for generation of functional oocytes as well as for early embryo development following fertilization, as the fertilized <italic>TUT4/7cKO</italic> did not develop past two-pronuclei stage [<xref ref-type="bibr" rid="RSTB20180162C35">35</xref>]. The early embryo is transcriptionally inactive and relies on maternally deposited transcripts. Thus, the regulation of transcript supply implies mostly poly(A) tail length adjustments and uridylation-induced degradation of certain transcripts at the completion of a programmed developmental stage. The global effect of TUTases and uridylation in oogenesis (and likely embryogenesis) apparently requires oligouridine tails as the ratio of oligo- to monouridylated RNAs is significantly higher in oocytes than in other investigated mouse cell types and tissues [<xref ref-type="bibr" rid="RSTB20180162C35">35</xref>]. TUT4/7 depletion resulted in a deregulation of a group of transcripts that were upregulated in <italic>TUT4/7cKO</italic> oocytes and lacked oligouridine tails present in the control <italic>TUT4/7CTL</italic> oocytes, while a pool of transcripts remained unchanged between these test conditions. It seems awkward, however, that only a minor fraction of less than 2% of transcripts was found uridylated in the control oocytes (and other cells) in this study. The above observations thus suggest that the specificity of TUT4/7-mediated uridylation is important, leading to elimination of only a strictly defined cohort of transcripts and thus likely allowing for smooth maternal-to-zygotic transition. Such conclusions were only recently made also for <italic>X. laevis</italic> and zebrafish [<xref ref-type="bibr" rid="RSTB20180162C192">192</xref>]. By using a morpholino-induced conditional depletion of TUT4/7 homologues in <italic>X. laevis</italic> and zebrafish embryos it has been demonstrated that the TUT4/7-mediated uridylation is at the onset of maternal transcriptome clearance during maternal-to-zygotic transition at 4–6 h post fertilization [<xref ref-type="bibr" rid="RSTB20180162C192">192</xref>]. On the basis of these reports it becomes apparent that TUTases are especially needed in oogenesis and at early stages of embryo development.</p>
</sec>
<sec id="s3b4">
<label>(iv)</label>
<title>Uridylation of snRNA, tRNA and other RNA polymerase III transcripts</title>
<p>TUTases play roles in the regulation of a cohort of other RNA species in the cytoplasm. Among them are snRNAs that constitute integral parts of the pre-mRNA splicing catalysing spliceosome [<xref ref-type="bibr" rid="RSTB20180162C193">193</xref>]. Four of these RNAs—<italic>U1</italic>, <italic>U2</italic>, <italic>U4</italic>, <italic>U5</italic>—are transcribed by RNA polymerase II and one—<italic>U6</italic> snRNA—by RNA polymerase III, and all undergo a series of specialized processing steps both in the nucleus and in the cytoplasm [<xref ref-type="bibr" rid="RSTB20180162C137">137</xref>,<xref ref-type="bibr" rid="RSTB20180162C194">194</xref>]. Misprocessed snRNAs are uridylated by the TUTases and destined for DIS3L2-mediated decay [<xref ref-type="bibr" rid="RSTB20180162C140">140</xref>,<xref ref-type="bibr" rid="RSTB20180162C188">188</xref>,<xref ref-type="bibr" rid="RSTB20180162C195">195</xref>]. Initially, the TUT-DIS3L2 pathway was considered in nuclear snRNA processing and biogenesis. However, this possibility was ruled out [<xref ref-type="bibr" rid="RSTB20180162C140">140</xref>], which was later corroborated by the discovery of a nuclear snRNA processing 3′–5′ exoribonuclease—TOE1 [<xref ref-type="bibr" rid="RSTB20180162C196">196</xref>].</p>
<p>In a CLIP assay with a mutant DIS3L2 (D391N), uridylation sites have been found within bodies of all mature rRNA species: <italic>28S</italic>, <italic>18S</italic>, <italic>5.8S</italic> and the Pol III-transcribed <italic>5S</italic> rRNAs, and less so, but also present, in the so-called ETS and ITS parts of the rRNA precursor [<xref ref-type="bibr" rid="RSTB20180162C188">188</xref>]. The identified fragments most likely represent degradation intermediates, thus strongly suggesting that rRNAs are also targets of (most likely) TUT4/7-mediated uridylation and rely on subsequent degradation by DIS3L2 [<xref ref-type="bibr" rid="RSTB20180162C188">188</xref>].</p>
<p>Transcription by Pol III complements mammalian RNAs with diverse short and usually highly structured non-coding RNAs [<xref ref-type="bibr" rid="RSTB20180162C197">197</xref>,<xref ref-type="bibr" rid="RSTB20180162C198">198</xref>]. Importantly, all these transcripts end in 4–5 Us, which is a termination signal for Pol III-mediated transcription. Recent evidence confirms the generality of the cytoplasmic uridylation-induced DIS3L2-executed RNA decay in regard to many Pol III transcripts including U6 snRNA, snoRNA, tRNA, <italic>Y</italic> and <italic>vault</italic> RNA, <italic>Rmrp</italic>, <italic>7SL</italic>, <italic>BC200</italic> and several others [<xref ref-type="bibr" rid="RSTB20180162C140">140</xref>,<xref ref-type="bibr" rid="RSTB20180162C188">188</xref>,<xref ref-type="bibr" rid="RSTB20180162C195">195</xref>]. Transfer RNAs (tRNAs) are likely some of the most notable regulated RNAs as they play an essential function in protein biosynthesis. In their CLIP study, Ustanienko <italic>et al.</italic> [<xref ref-type="bibr" rid="RSTB20180162C188">188</xref>] showed mapping to tRNA truncated within the T-loop or to the 3′-end tRNA trailers, which implied that uridylation-induced DIS3L2 decay involves misprocessed extended forms of tRNAs and likely might also regulate properly processed tRNAs. <italic>Y</italic> and <italic>vault</italic> RNA (<italic>VTRNA</italic>) are short RNAs that form RNP assemblies in the cytoplasm. In fact, <italic>VTRNA</italic>s form likely the biggest known human cytoplasmic RNPs with a mass of approximately 13 MDa and overall dimensions of 40 × 40 × 70 nm [<xref ref-type="bibr" rid="RSTB20180162C199">199</xref>]. While Y RNA likely play a role in DNA replication and RNA processing [<xref ref-type="bibr" rid="RSTB20180162C74">74</xref>], <italic>VTRNAs</italic> have been linked to multidrug resistance and anti-apoptotic effects in cancer cells [<xref ref-type="bibr" rid="RSTB20180162C200">200</xref>]. Moreover, both ncRNA types might serve as precursors for the generation of short RNA, svRNA and Ys RNA, which likely act in post-transcriptional regulation of some mRNAs [<xref ref-type="bibr" rid="RSTB20180162C201">201</xref>,<xref ref-type="bibr" rid="RSTB20180162C202">202</xref>]. The importance of these RNAs in cells has not been firmly established. Nevertheless, they are among the most prominent TUT4/7-DIS3L2 substrates [<xref ref-type="bibr" rid="RSTB20180162C140">140</xref>,<xref ref-type="bibr" rid="RSTB20180162C188">188</xref>,<xref ref-type="bibr" rid="RSTB20180162C195">195</xref>]. Another Pol III transcript regulated by uridylation and DIS3L2-mediated decay is <italic>Rmrp</italic>. Its function in mammalian cells is not clear but mutations in human <italic>RMRP</italic> gene lead to <italic>cartilage–hair hypoplasia</italic> (CHH), manifesting in a few serious deficiencies [<xref ref-type="bibr" rid="RSTB20180162C203">203</xref>]. Imprecise 3′ ends of <italic>Rmrp</italic> RNAs have been found heavily oligo- and polyuridylated in DIS3L2 co-immunoprecipitates, with as many as 26 3′ uridines and a median length of 12 uridines [<xref ref-type="bibr" rid="RSTB20180162C195">195</xref>]. Interestingly, since Pol III-transcribed ncRNAs were the dominant fraction of RNAs enriched in DIS3L2 co-IPs, the authors proposed that ncRNAs are prime targets of the uridylation-induced DIS3L2-executed decay [<xref ref-type="bibr" rid="RSTB20180162C195">195</xref>]. This, however, might at least partially result from particular features of the short ncRNAs, namely: (i) naturally occurring 4–5 Us at their 3′ ends, which might remain free from base-pairing interactions and protrude from RNPs [<xref ref-type="bibr" rid="RSTB20180162C140">140</xref>,<xref ref-type="bibr" rid="RSTB20180162C187">187</xref>,<xref ref-type="bibr" rid="RSTB20180162C188">188</xref>,<xref ref-type="bibr" rid="RSTB20180162C195">195</xref>]; and (ii) their stable structures that might effectively stall DIS3L2 on these substrates (Warkocki <italic>et al</italic>. 2016, unpublished). <italic>In vitro</italic> reconstitution of TUTase activity and DIS3L2-mediated RNA degradation assured that at least in the case of the tested tRNA, <italic>Y</italic> and <italic>vault</italic> RNAs and <italic>Rmrp</italic> the concerted uridylation-induced 3′–5′ decay does not require other protein factors besides a TUTase and DIS3L2 [<xref ref-type="bibr" rid="RSTB20180162C140">140</xref>,<xref ref-type="bibr" rid="RSTB20180162C188">188</xref>,<xref ref-type="bibr" rid="RSTB20180162C195">195</xref>].</p>
</sec>
<sec id="s3b5">
<label>(v)</label>
<title>Uridylation of RNA viruses and human LINE-1 retrotransposons</title>
<p>It has been demonstrated that exogenous RNAs of viral origin are also heavily uridylated with as many as a few tens of uridines appended to their 3′ ends [<xref ref-type="bibr" rid="RSTB20180162C204">204</xref>]. Indeed, a recent report demonstrated that RNA viruses constitute an important target for uridylation by TUT4/7 in <italic>C. elegans</italic>, human A549 cells and murine fibroblasts [<xref ref-type="bibr" rid="RSTB20180162C205">205</xref>]. While in wild-type cells a significant fraction of viral RNAs was uridylated, in cells lacking TUTases this fraction was reduced to nearly 0 and the percentage of infected cells was also significantly higher than in the wild-type cells. Thus the authors concluded that uridylation by TUT4/7 constitutes a defence mechanism against infections by RNA viruses [<xref ref-type="bibr" rid="RSTB20180162C205">205</xref>]. Last but not least, a recent study demonstrated a potent multi-layer restriction of human LINE-1 retrotransposons by uridylation [<xref ref-type="bibr" rid="RSTB20180162C206">206</xref>]. LINE-1 is a group of vertebrate retrotransposons that in humans constitute nearly 17% of the entire genome [<xref ref-type="bibr" rid="RSTB20180162C207">207</xref>,<xref ref-type="bibr" rid="RSTB20180162C208">208</xref>]. They proliferate by a copy-and-paste mechanism involving transcription and reintegration into a new site within the genomic DNA by a so-called target-primed reverse transcription (TPRT) mechanism potentially leading to <italic>de novo</italic> mutations in the germline owing to the temporal loss of epigenetic marks that silence LINE-1 in somatic cells [<xref ref-type="bibr" rid="RSTB20180162C189">189</xref>]. Nevertheless, LINE-1s are also expressed in some somatic cells, especially neurons [<xref ref-type="bibr" rid="RSTB20180162C209">209</xref>–<xref ref-type="bibr" rid="RSTB20180162C211">211</xref>]. They are also expressed in cancers [<xref ref-type="bibr" rid="RSTB20180162C212">212</xref>]. In contrast to other protein-coding mRNAs, uridylation of LINE-1 mRNA not only enhances degradation of otherwise extremely stable LINE-1 mRNAs but also, and most importantly, it might block initiation of reverse transcription during TPRT, which under normal conditions requires base-pairing of the poly(A) tail of LINE-1 mRNA with a short oligo(dT) stretch released from genomic DNA (<xref ref-type="fig" rid="RSTB20180162F3">figure 3</xref>) [<xref ref-type="bibr" rid="RSTB20180162C172">172</xref>,<xref ref-type="bibr" rid="RSTB20180162C206">206</xref>,<xref ref-type="bibr" rid="RSTB20180162C213">213</xref>]. Such base pairing cannot be achieved between the oligo(U) tail of mRNA and genomic oligo(dT) [<xref ref-type="bibr" rid="RSTB20180162C206">206</xref>]. Importantly, TUT4 and TUT7 show slightly different effects on LINE-1 mRNA steady-state levels and stabilities that likely results from TUT4, but not TUT7, enrichment in cytoplasmic <italic>foci</italic> [<xref ref-type="bibr" rid="RSTB20180162C206">206</xref>].
<fig id="RSTB20180162F3" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Involvement of TUT4 and TUT7 in LINE-1 retrotransposon restriction. Panel (<italic>a</italic>) highlighted in green shows the LINE-1 retrotransposon life cycle. An active LINE-1 copy is transcribed by RNA polymerase II into a <italic>bicistronic</italic> LINE-1 mRNA and exported into cytoplasm. There LINE-1 proteins—L1-ORF1p (a LINE-1 mRNA chaperone) and L1-ORF2p (a dsDNA nickase and reverse transcriptase) are translated, leading to the formation of a LINE-1 RNP. The RNP is re-imported into the nucleus where the L1-ORF2p nicks genomic DNA, releasing a short (approx. 4–6 nt) stretch of dT. This base-pairs with the LINE-1 mRNA poly(A) tail and so becomes a primer for reverse transcription (known as target-primed reverse transcription—TPRT). Following TPRT, a new LINE-1 copy is ultimately inserted into the genomic DNA by a not well understood mechanism. Panel (<italic>b</italic>) highlighted in pink shows a postulated model of a cooperative activity of MOV10 helicase/RNPase protein and TUT4/TUT7 leading to restriction of LINE-1 retrotransposition. Following the export of LINE-1 mRNA into cytoplasm, MOV10 actively removes L1-ORF1p from LINE-1 mRNA 3′ end and exposes it to enzymatic activity including uridylation by TUT7 and/or TUT7. Uridylated LINE-1 mRNAs undergo decay in the cytoplasm but some LINE-1 mRNPs re-enter the nucleus. There, however, the 3′ uridines do not base-pair with the exposed genomic oligo(dT), thus the reverse transcription cannot commence. As a result, LINE-1 retrotransposition is efficiently restricted by a multi-layered mechanism.</p></caption><graphic xlink:href="rstb20180162-g3"></graphic></fig></p>
<p>Biochemical investigations demonstrated that structured RNAs with their 3′ end involved in base-pairing acquire none or shorter U-tails than non-structured substrates or substrates with their 3′ ends clearly protruding from the main RNA body [<xref ref-type="bibr" rid="RSTB20180162C140">140</xref>,<xref ref-type="bibr" rid="RSTB20180162C214">214</xref>]. Thus it seems that a mechanistic prerequisite for uridylation might involve resolving secondary and tertiary structures or removal of proteins (like PABPC [<xref ref-type="bibr" rid="RSTB20180162C182">182</xref>]), both of which occlude 3′ ends and prevent uridylation of some physiological TUT substrates. One could expect helicases and RNPases (proteins destabilizing RNA–protein interactions) to functionally cooperate with the TUTases by removing proteins or resolving secondary and tertiary structures to promote uridylation. Indeed, such a functional cooperativity mechanism involving MOV10 helicase and TUT4/7 has been recently proposed for uridylation of LINE-1 mRNAs that otherwise are tightly packed and protected from external enzymatic activity by a shell formed by multiple copies of the LINE-1 L1-ORF1p chaperone protein (<xref ref-type="fig" rid="RSTB20180162F3">figure 3</xref>) [<xref ref-type="bibr" rid="RSTB20180162C206">206</xref>].</p>
</sec>
</sec>
</sec>
<sec id="s4">
<label>4.</label>
<title>Conclusion</title>
<p>Eleven mammalian TENTs play important roles in post-transcriptional gene expression regulatory mechanisms acting in nucleus, cytoplasm and mitochondria. They mainly control the stability of RNA species. Cytoplasmic ncPAPs (TENT2, TENT5) stabilize substrate mRNAs, while polyadenylation by the nuclear counterparts (TENT4A/B) seems to have mixed effects. Such enzymes can induce exosome-mediated decay or, because of their promiscuous nucleotide specificity with substantial incorporation of GMP residues within the poly(A) tails of mRNA molecules, they can stabilize mRNAs when they are exported into the cytoplasm. Cytoplasmic TUTases (TUT4/TUT7) mostly induce RNA decay, while nuclear TUT1 stabilizes U6 snRNA. Importantly, although in some cases knowledge about their role and mechanism of action is already substantial, in many cases, TENT5 enzymes for instance, we are just at the beginning of the journey. It is also important to point out that there are several substantial controversies in the field, some of which were described herein. Thus, further research is clearly needed to understand how TENTs regulate gene expression in mammals with a closer look at the subcellular, cellular, tissue and developmental stage contexts.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We thank Janina Durys for English language editing. Karolina Drążkowska and Dmytro Pandakov are acknowledged for critically reading the manuscript. Z.W. thanks Łucja Potyrała for helpful discussions and a generous donation.</p>
</ack>
<sec id="s5">
<title>Data accessibility</title>
<p>This article has no additional data.</p>
</sec>
<sec id="s6">
<title>Authors' contributions</title>
<p>Z.W. composed the final manuscript, wrote the TUT4 and TUT7 sections, prepared figures and the table; V.L. wrote the TENT4 and MTPAP sections; O.G. wrote the TENT2 and TENT5 sections; S.M. wrote the TENT1 section; A.D. supervised the work and composed the final manuscript.</p>
</sec>
<sec id="s7" sec-type="COI-statement">
<title>Competing interests</title>
<p>We declare we have no competing interests.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work received support from the National Science Centre (NCN, UMO-2017/26/D/NZ1/00887, SONATA-13 to Z.W., including open access charges), the European Research Council (Starting Grant 309419 to A.D.) and the Foundation for Polish Science (TEAM/2016-1/3 to A.D.) (NCN, UMO-2017/27/B/NZ2/01234, OPUS 14 to S.M.).</p>
</sec>
<ref-list>
<title>References</title>
<ref id="RSTB20180162C1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Keller</surname><given-names>W</given-names></name></person-group>
<year>2007</year>
<article-title>RNA-specific ribonucleotidyl transferases</article-title>. <source/>RNA
<volume>13</volume>, <fpage>1834</fpage>–<lpage>1849</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.652807</pub-id>)<pub-id pub-id-type="pmid">17872511</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Norbury</surname><given-names>CJ</given-names></name></person-group>
<year>2010</year>
<article-title>Polyadenylation and beyond: emerging roles for noncanonical poly(A) polymerases</article-title>. <source/>Wiley Interdiscip. Rev. RNA
<volume>1</volume>, <fpage>142</fpage>–<lpage>151</lpage>. (<pub-id pub-id-type="doi">10.1002/wrna.16</pub-id>)<pub-id pub-id-type="pmid">21956911</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Norbury</surname><given-names>CJ</given-names></name></person-group>
<year>2013</year>
<article-title>Cytoplasmic RNA: a case of the tail wagging the dog</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>14</volume>, <fpage>643</fpage>–<lpage>653</lpage>. (<pub-id pub-id-type="doi">10.1038/nrm3645</pub-id>)<pub-id pub-id-type="pmid">23989958</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aravind</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Koonin</surname><given-names>EV</given-names></name></person-group>
<year>1999</year>
<article-title>DNA polymerase β-like nucleotidyltransferase superfamily: identification of three new families, classification and evolutionary history</article-title>. <source/>Nucleic Acids Res.
<volume>27</volume>, <fpage>1609</fpage>–<lpage>1618</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/27.7.1609</pub-id>)<pub-id pub-id-type="pmid">10075991</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuchta</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Knizewski</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wyrwicz</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Rychlewski</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ginalski</surname><given-names>K</given-names></name></person-group>
<year>2009</year>
<article-title>Comprehensive classification of nucleotidyltransferase fold proteins: identification of novel families and their representatives in human</article-title>. <source/>Nucleic Acids Res.
<volume>37</volume>, <fpage>7701</fpage>–<lpage>7714</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkp854</pub-id>)<pub-id pub-id-type="pmid">19833706</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balbo</surname><given-names>PB</given-names></name>, <name name-style="western"><surname>Bohm</surname><given-names>A</given-names></name></person-group>
<year>2007</year>
<article-title>Mechanism of poly(A) polymerase: structure of the enzyme-MgATP-RNA ternary complex and kinetic analysis</article-title>. <source/>Structure
<volume>15</volume>, <fpage>1117</fpage>–<lpage>1131</lpage>. (<pub-id pub-id-type="doi">10.1016/j.str.2007.07.010</pub-id>)<pub-id pub-id-type="pmid">17850751</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwak</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Wickens</surname><given-names>M</given-names></name></person-group>
<year>2007</year>
<article-title>A family of poly(U) polymerases</article-title>. <source/>RNA
<volume>13</volume>, <fpage>860</fpage>–<lpage>867</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.514007</pub-id>)<pub-id pub-id-type="pmid">17449726</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stagno</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Aphasizheva</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Aphasizhev</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Luecke</surname><given-names>H</given-names></name></person-group>
<year>2007</year>
<article-title>Dual role of the RNA substrate in selectivity and catalysis by terminal uridylyl transferases</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>104</volume>, <fpage>14 634</fpage>–<lpage>14 639</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0704259104</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stagno</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Aphasizheva</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Rosengarth</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Luecke</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Aphasizhev</surname><given-names>R</given-names></name></person-group>
<year>2007</year>
<article-title>UTP-bound and Apo structures of a minimal RNA uridylyltransferase</article-title>. <source/>J. Mol. Biol.
<volume>366</volume>, <fpage>882</fpage>–<lpage>899</lpage>. (<pub-id pub-id-type="doi">10.1016/j.jmb.2006.11.065</pub-id>)<pub-id pub-id-type="pmid">17189640</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rissland</surname><given-names>OS</given-names></name>, <name name-style="western"><surname>Mikulasova</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Norbury</surname><given-names>CJ</given-names></name></person-group>
<year>2007</year>
<article-title>Efficient RNA polyuridylation by noncanonical poly(A) polymerases</article-title>. <source/>Mol. Cell. Biol.
<volume>27</volume>, <fpage>3612</fpage>–<lpage>3624</lpage>. (<pub-id pub-id-type="doi">10.1128/MCB.02209-06</pub-id>)<pub-id pub-id-type="pmid">17353264</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colgan</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Manley</surname><given-names>JL</given-names></name></person-group>
<year>1997</year>
<article-title>Mechanism and regulation of mRNA polyadenylation</article-title>. <source/>Genes Dev.
<volume>11</volume>, <fpage>2755</fpage>–<lpage>2766</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.11.21.2755</pub-id>)<pub-id pub-id-type="pmid">9353246</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Proudfoot</surname><given-names>NJ</given-names></name></person-group>
<year>2011</year>
<article-title>Ending the message: poly(A) signals then and now</article-title>. <source/>Genes Dev.
<volume>25</volume>, <fpage>1770</fpage>–<lpage>1782</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.17268411</pub-id>)<pub-id pub-id-type="pmid">21896654</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laishram</surname><given-names>RS</given-names></name></person-group>
<year>2014</year>
<article-title>Poly(A) polymerase (PAP) diversity in gene expression—Star-PAP vs canonical PAP</article-title>. <source/>FEBS Lett.
<volume>588</volume>, <fpage>2185</fpage>–<lpage>2197</lpage>. (<pub-id pub-id-type="doi">10.1016/j.febslet.2014.05.029</pub-id>)<pub-id pub-id-type="pmid">24873880</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C-YA</given-names></name>, <name name-style="western"><surname>Shyu</surname><given-names>A-B</given-names></name></person-group>
<year>2011</year>
<article-title>Mechanisms of deadenylation-dependent decay</article-title>. <source/>Wiley Interdiscip. Rev. RNA
<volume>2</volume>, <fpage>167</fpage>–<lpage>183</lpage>. (<pub-id pub-id-type="doi">10.1002/wrna.40</pub-id>)<pub-id pub-id-type="pmid">21957004</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Eckmann</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Kadyk</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Wickens</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kimble</surname><given-names>J</given-names></name></person-group>
<year>2002</year>
<article-title>A regulatory cytoplasmic poly(A) polymerase in <italic>Caenorhabditis elegans</italic></article-title>. <source/>Nature
<volume>419</volume>, <fpage>312</fpage>–<lpage>316</lpage>. (<pub-id pub-id-type="doi">10.1038/nature01039</pub-id>)<pub-id pub-id-type="pmid">12239571</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnard</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Manley</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name></person-group>
<year>2004</year>
<article-title>Symplekin and xGLD-2 are required for CPEB-mediated cytoplasmic polyadenylation</article-title>. <source/>Cell
<volume>119</volume>, <fpage>641</fpage>–<lpage>651</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2004.10.029</pub-id>)<pub-id pub-id-type="pmid">15550246</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rouhana</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Buter</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Jae</surname><given-names>EK</given-names></name>, <name name-style="western"><surname>Schiltz</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kelley</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Landry</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Wickens</surname><given-names>M</given-names></name></person-group>
<year>2005</year>
<article-title>Vertebrate GLD2 poly(A) polymerases in the germline and the brain</article-title>. <source/>RNA
<volume>11</volume>, <fpage>1117</fpage>–<lpage>1130</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.2630205</pub-id>)<pub-id pub-id-type="pmid">15987818</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mendez</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Murthy</surname><given-names>KGK</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Manley</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name></person-group>
<year>2000</year>
<article-title>Phosphorylation of CPEB by Eg2 mediates the recruitment of CPSF into an active cytoplasmic polyadenylation complex</article-title>. <source/>Mol. Cell
<volume>6</volume>, <fpage>1253</fpage>–<lpage>1259</lpage>. (<pub-id pub-id-type="doi">10.1016/S1097-2765(00)00121-0</pub-id>)<pub-id pub-id-type="pmid">11106762</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sartain</surname><given-names>CV</given-names></name>, <name name-style="western"><surname>Pleiss</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Wolfner</surname><given-names>MF</given-names></name></person-group>
<year>2013</year>
<article-title>Cytoplasmic polyadenylation is a major mRNA regulator during oogenesis and egg activation in <italic>Drosophila</italic></article-title>. <source/>Dev. Biol.
<volume>383</volume>, <fpage>121</fpage>–<lpage>131</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ydbio.2013.08.013</pub-id>)<pub-id pub-id-type="pmid">23978535</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name></person-group>
<year>2006</year>
<article-title>CDK1 and calcineurin regulate Maskin association with eIF4E and translational control of cell cycle progression</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>13</volume>, <fpage>1128</fpage>–<lpage>1134</lpage>. (<pub-id pub-id-type="doi">10.1038/nsmb1169</pub-id>)<pub-id pub-id-type="pmid">17086181</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name></person-group>
<year>2006</year>
<article-title>Opposing polymerase-deadenylase activities regulate cytoplasmic polyadenylation</article-title>. <source/>Mol. Cell
<volume>24</volume>, <fpage>173</fpage>–<lpage>183</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2006.08.016</pub-id>)<pub-id pub-id-type="pmid">17052452</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name></person-group>
<year>2007</year>
<article-title>RINGO/cdk1 and CPEB mediate poly(A) tail stabilization and translational regulation by ePAB</article-title>. <source/>Genes Dev.
<volume>21</volume>, <fpage>2571</fpage>–<lpage>2579</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.1593007</pub-id>)<pub-id pub-id-type="pmid">17938241</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakel</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bonneau</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Eckmann</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Conti</surname><given-names>E</given-names></name></person-group>
<year>2015</year>
<article-title>Structural basis for the activation of the <italic>C. elegans</italic> noncanonical cytoplasmic poly(A)-polymerase GLD-2 by GLD-3</article-title>. <source/>Proc. Natl. Acad. Sci. USA
<volume>112</volume>, <fpage>8614</fpage>–<lpage>8619</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1504648112</pub-id>)<pub-id pub-id-type="pmid">26124149</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarkissian</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mendez</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name></person-group>
<year>2004</year>
<article-title>Progesterone and insulin stimulation of CPEB-dependent polyadenylation is regulated by Aurora A and glycogen synthase kinase-3</article-title>. <source/>Genes Dev.
<volume>18</volume>, <fpage>48</fpage>–<lpage>61</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.1136004</pub-id>)<pub-id pub-id-type="pmid">14724178</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rouhana</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wickens</surname><given-names>M</given-names></name></person-group>
<year>2007</year>
<article-title>Autoregulation of GLD-2 cytoplasmic poly(A) polymerase</article-title>. <source/>RNA
<volume>13</volume>, <fpage>188</fpage>–<lpage>199</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.333507</pub-id>)<pub-id pub-id-type="pmid">17164476</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sartain</surname><given-names>CV</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Meisel</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Wolfner</surname><given-names>MF</given-names></name></person-group>
<year>2011</year>
<article-title>The poly(A) polymerase GLD2 is required for spermatogenesis in <italic>Drosophila melanogaster</italic></article-title>. <source/>Development
<volume>138</volume>, <fpage>1619</fpage>–<lpage>1629</lpage>. (<pub-id pub-id-type="doi">10.1242/dev.059618</pub-id>)<pub-id pub-id-type="pmid">21427144</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eckmann</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Crittenden</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Suh</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kimble</surname><given-names>J</given-names></name></person-group>
<year>2004</year>
<article-title>GLD-3 and control of the mitosis/meiosis decision in the germline of <italic>Caenorhabditis elegans</italic></article-title>. <source/>Genetics
<volume>168</volume>, <fpage>147</fpage>–<lpage>160</lpage>. (<pub-id pub-id-type="doi">10.1534/genetics.104.029264</pub-id>)<pub-id pub-id-type="pmid">15454534</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ivshina</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lasko</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name></person-group>
<year>2014</year>
<article-title>Cytoplasmic polyadenylation element binding proteins in development, health, and disease</article-title>. <source/>Annu. Rev. Cell Dev. Biol.
<volume>30</volume>, <fpage>393</fpage>–<lpage>415</lpage>. (<pub-id pub-id-type="doi">10.1146/annurev-cellbio-101011-155831</pub-id>)<pub-id pub-id-type="pmid">25068488</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name></person-group>
<year>2007</year>
<article-title>CPEB: a life in translation</article-title>. <source/>Trends Biochem. Sci.
<volume>32</volume>, <fpage>279</fpage>–<lpage>285</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tibs.2007.04.004</pub-id>)<pub-id pub-id-type="pmid">17481902</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C30">
<label>30</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Robertson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>R</given-names></name></person-group>
<year>2015</year>
<article-title>The maternal-to-zygotic transition in <italic>C. elegans</italic></article-title>. In <source/>Current Topics in Developmental Biology (ed. <person-group person-group-type="editor"><name name-style="western"><surname>Lipshitz</surname><given-names>HD</given-names></name></person-group>), pp. <fpage>1</fpage>–<lpage>42</lpage>. <publisher-loc>London, UK</publisher-loc>: <publisher-name>Elsevier Inc.</publisher-name> (<pub-id pub-id-type="doi">10.1016/bs.ctdb.2015.06.001</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwak</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ballantyne</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kimble</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wickens</surname><given-names>M</given-names></name></person-group>
<year>2004</year>
<article-title>Mammalian GLD-2 homologs are poly(A) polymerases</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>101</volume>, <fpage>4407</fpage>–<lpage>4412</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0400779101</pub-id>)<pub-id pub-id-type="pmid">15070731</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakanishi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kubota</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ishibashi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kumagai</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yamashita</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kashiwabara</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Miyado</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Baba</surname><given-names>T</given-names></name></person-group>
<year>2006</year>
<article-title>Possible role of mouse poly(A) polymerase mGLD-2 during oocyte maturation</article-title>. <source/>Dev. Biol.
<volume>289</volume>, <fpage>115</fpage>–<lpage>126</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ydbio.2005.10.017</pub-id>)<pub-id pub-id-type="pmid">16325797</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakanishi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kumagai</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kimura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sakurai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kimura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kashiwabara</surname><given-names>S ichi</given-names></name>, <name name-style="western"><surname>Baba</surname><given-names>T</given-names></name></person-group>
<year>2007</year>
<article-title>Disruption of mouse poly(A) polymerase mGLD-2 does not alter polyadenylation status in oocytes and somatic cells</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>364</volume>, <fpage>14</fpage>–<lpage>19</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbrc.2007.09.096</pub-id>)<pub-id pub-id-type="pmid">17927953</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kashiwabara</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>
<year>2002</year>
<article-title>Regulation of spermatogenesis by testis-specific, cytoplasmic poly(A) polymerase TPAP</article-title>. <source/>Science
<volume>298</volume>, <fpage>1999</fpage>–<lpage>2002</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1074632</pub-id>)<pub-id pub-id-type="pmid">12471261</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morgan</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>MRNA 3′ uridylation and poly(A) tail length sculpt the mammalian maternal transcriptome</article-title>. <source/>Nature
<volume>548</volume>, <fpage>347</fpage>–<lpage>351</lpage>. (<pub-id pub-id-type="doi">10.1038/nature23318</pub-id>)<pub-id pub-id-type="pmid">28792939</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swanger</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>He</surname><given-names>YA</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Bassell</surname><given-names>GJ</given-names></name></person-group>
<year>2013</year>
<article-title>Dendritic GluN2A synthesis mediates activity-induced NMDA receptor insertion</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>8898</fpage>–<lpage>8908</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0289-13.2013</pub-id>)<pub-id pub-id-type="pmid">23678131</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamagishi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Tsusaka</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mitsunaga</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Maehata</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hoshino</surname><given-names>SI</given-names></name></person-group>
<year>2016</year>
<article-title>The STAR protein QKI-7 recruits PAPD4 to regulate post-transcriptional polyadenylation of target mRNAs</article-title>. <source/>Nucleic Acids Res.
<volume>44</volume>, <fpage>2475</fpage>–<lpage>2490</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkw118</pub-id>)<pub-id pub-id-type="pmid">26926106</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Novoa</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Gallego</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ferreira</surname><given-names>PG</given-names></name>, <name name-style="western"><surname>Mendez</surname><given-names>R</given-names></name></person-group>
<year>2010</year>
<article-title>Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational control</article-title>. <source/>Nat. Cell Biol.
<volume>12</volume>, <fpage>447</fpage>–<lpage>456</lpage>. (<pub-id pub-id-type="doi">10.1038/ncb2046</pub-id>)<pub-id pub-id-type="pmid">20364142</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katoh</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sakaguchi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Miyauchi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Kashiwabara</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Baba</surname><given-names>T</given-names></name></person-group>
<year>2009</year>
<article-title>Selective stabilization of mammalian microRNAs by 3′ adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2</article-title>. <source/>Genes Dev.
<volume>23</volume>, <fpage>433</fpage>–<lpage>438</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.1761509</pub-id>)<pub-id pub-id-type="pmid">19240131</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D'Ambrogio</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Udagawa</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mello</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name></person-group>
<year>2012</year>
<article-title>Specific miRNA stabilization by Gld2-catalyzed monoadenylation</article-title>. <source/>Cell Rep.
<volume>2</volume>, <fpage>1537</fpage>–<lpage>1545</lpage>. (<pub-id pub-id-type="doi">10.1016/j.celrep.2012.10.023</pub-id>)<pub-id pub-id-type="pmid">23200856</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mansur</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ivshina</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Schaevitz</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Stackpole</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gujja</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>YJK</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name></person-group>
<year>2016</year>
<article-title>Gld2-catalyzed 3′ monoadenylation of miRNAs in the hippocampus has no detectable effect on their stability or on animal behavior</article-title>. <source/>RNA
<volume>22</volume>, <fpage>1492</fpage>–<lpage>1499</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.056937.116</pub-id>)<pub-id pub-id-type="pmid">27495319</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heo</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Ha</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Kwon</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>VN</given-names></name></person-group>
<year>2012</year>
<article-title>Mono-uridylation of pre-microRNA as a key step in the biogenesis of group II let-7 microRNAs</article-title>. <source/>Cell
<volume>151</volume>, <fpage>521</fpage>–<lpage>532</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2012.09.022</pub-id>)<pub-id pub-id-type="pmid">23063654</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>B</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>TUT7 controls the fate of precursor microRNAs by using three different uridylation mechanisms</article-title>. <source/>EMBO J.
<volume>34</volume>, <fpage>1801</fpage>–<lpage>1815</lpage>. (<pub-id pub-id-type="doi">10.15252/embj.201590931</pub-id>)<pub-id pub-id-type="pmid">25979828</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Jo</surname><given-names>DHS</given-names></name>, <name name-style="western"><surname>Heinemann</surname><given-names>IU</given-names></name></person-group>
<year>2016</year>
<article-title>Nucleotide specificity of the human terminal nucleotidyltransferase Gld2 (TUT2)</article-title>. <source/>RNA
<volume>2</volume>, <fpage>1239</fpage>–<lpage>1249</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.056077.116</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LaCava</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Houseley</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Saveanu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Petfalski</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Jacquier</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tollervey</surname><given-names>D</given-names></name></person-group>
<year>2005</year>
<article-title>RNA degradation by the exosome is promoted by a nuclear polyadenylation complex</article-title>. <source/>Cell
<volume>121</volume>, <fpage>713</fpage>–<lpage>724</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2005.04.029</pub-id>)<pub-id pub-id-type="pmid">15935758</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Falk</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Weir</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Hentschel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Reichelt</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bonneau</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Conti</surname><given-names>E</given-names></name></person-group>
<year>2014</year>
<article-title>The molecular architecture of the TRAMP complex reveals the organization and interplay of its two catalytic activities</article-title>. <source/>Mol. Cell
<volume>55</volume>, <fpage>856</fpage>–<lpage>867</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2014.07.020</pub-id>)<pub-id pub-id-type="pmid">25175027</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Butler</surname><given-names>JS</given-names></name></person-group>
<year>2013</year>
<article-title>Nuclear RNA surveillance: role of TRAMP in controlling exosome specificity</article-title>. <source/>Wiley Interdiscip. Rev. RNA
<volume>4</volume>, <fpage>217</fpage>–<lpage>231</lpage>. (<pub-id pub-id-type="doi">10.1002/wrna.1155</pub-id>)<pub-id pub-id-type="pmid">23417976</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Saha</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Paira</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>B</given-names></name></person-group>
<year>2018</year>
<article-title>Nuclear mRNA surveillance mechanisms: function and links to human disease</article-title>. <source/>J. Mol. Biol.
<volume>430</volume>, <fpage>1993</fpage>–<lpage>2013</lpage>. (<pub-id pub-id-type="doi">10.1016/j.jmb.2018.05.009</pub-id>)<pub-id pub-id-type="pmid">29758258</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lubas</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Christensen</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Kristiansen</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Domanski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Falkenby</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Lykke-Andersen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Andersen</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Dziembowski</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Heick Jensen</surname><given-names>T</given-names></name></person-group>
<year>2011</year>
<article-title>Interaction profiling identifies the human nuclear exosome targeting complex</article-title>. <source/>Mol. Cell
<volume>43</volume>, <fpage>624</fpage>–<lpage>637</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2011.06.028</pub-id>)<pub-id pub-id-type="pmid">21855801</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogami</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hoshino</surname><given-names>S ichi</given-names></name></person-group>
<year>2013</year>
<article-title>Molecular cloning and characterization of a novel isoform of the non-canonical poly(A) polymerase PAPD7</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>432</volume>, <fpage>135</fpage>–<lpage>140</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbrc.2013.01.072</pub-id>)<pub-id pub-id-type="pmid">23376078</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stumpf</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Moreno</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Olshen</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Ruggero</surname><given-names>D</given-names></name></person-group>
<year>2013</year>
<article-title>The translational landscape of the mammalian cell cycle</article-title>. <source/>Mol. Cell
<volume>52</volume>, <fpage>574</fpage>–<lpage>582</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2013.09.018</pub-id>)<pub-id pub-id-type="pmid">24120665</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation</article-title>. <source/>Science
<volume>361</volume>, <fpage>701</fpage>–<lpage>704</lpage>. (<pub-id pub-id-type="doi">10.1126/science.aam5794</pub-id>)<pub-id pub-id-type="pmid">30026317</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nag</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Steitz</surname><given-names>JA</given-names></name></person-group>
<year>2012</year>
<article-title>Tri-snRNP-associated proteins interact with subunits of the TRAMP and nuclear exosome complexes, linking RNA decay and pre-mRNA splicing</article-title>. <source/>RNA Biol.
<volume>9</volume>, <fpage>334</fpage>–<lpage>342</lpage>. (<pub-id pub-id-type="doi">10.4161/rna.19431</pub-id>)<pub-id pub-id-type="pmid">22336707</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bessonov</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Anokhina</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Will</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Urlaub</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lührmann</surname><given-names>R</given-names></name></person-group>
<year>2008</year>
<article-title>Isolation of an active step I spliceosome and composition of its RNP core</article-title>. <source/>Nature
<volume>452</volume>, <fpage>846</fpage>–<lpage>850</lpage>. (<pub-id pub-id-type="doi">10.1038/nature06842</pub-id>)<pub-id pub-id-type="pmid">18322460</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wakiyama</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ogami</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Iwaoka</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Aoki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hoshino</surname><given-names>SI</given-names></name></person-group>
<year>2018</year>
<article-title>MicroRNP-mediated translational activation of nonadenylated mRNAs in a mammalian cell-free system</article-title>. <source/>Genes Cells
<volume>23</volume>, <fpage>332</fpage>–<lpage>344</lpage>. (<pub-id pub-id-type="doi">10.1111/gtc.12580</pub-id>)<pub-id pub-id-type="pmid">29626383</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mullen</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Marzluff</surname><given-names>WF</given-names></name></person-group>
<year>2008</year>
<article-title>Degradation of histone mRNA requires oligouridylation followed by decapping and simultaneous degradation of the mRNA both 5′ to 3′ and 3′ to 5′</article-title>. <source/>Genes Dev.
<volume>22</volume>, <fpage>50</fpage>–<lpage>65</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.1622708</pub-id>)<pub-id pub-id-type="pmid">18172165</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rammelt</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bilen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zavolan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Keller</surname><given-names>W</given-names></name></person-group>
<year>2011</year>
<article-title>PAPD5, a noncanonical poly(A) polymerase with an unusual RNA-binding motif</article-title>. <source/>RNA
<volume>17</volume>, <fpage>1737</fpage>–<lpage>1746</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.2787011</pub-id>)<pub-id pub-id-type="pmid">21788334</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>M-J</given-names></name>, <name name-style="western"><surname>West</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Norbury</surname><given-names>CJ</given-names></name></person-group>
<year>2011</year>
<article-title>The human cytoplasmic RNA terminal U-transferase ZCCHC11 targets histone mRNAs for degradation</article-title>. <source/>RNA
<volume>17</volume>, <fpage>39</fpage>–<lpage>44</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.2252511</pub-id>)<pub-id pub-id-type="pmid">21051505</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carneiro</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Carvalho</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Braga</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rino</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Milligan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tollervey</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Carmo-Fonseca</surname><given-names>M</given-names></name></person-group>
<year>2007</year>
<article-title>Depletion of the yeast nuclear exosome subunit Rrp6 results in accumulation of polyadenylated RNAs in a discrete domain within the nucleolus</article-title>. <source/>Mol. Cell. Biol.
<volume>27</volume>, <fpage>4157</fpage>–<lpage>4165</lpage>. (<pub-id pub-id-type="doi">10.1128/MCB.00120-07</pub-id>)<pub-id pub-id-type="pmid">17403903</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaňáčová</surname><given-names>Š</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Blank</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Dettwiler</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Friedlein</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Langen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Keith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Keller</surname><given-names>W</given-names></name></person-group>
<year>2005</year>
<article-title>A new yeast poly(A) polymerase complex involved in RNA quality control</article-title>. <source/>PLoS Biol.
<volume>3</volume>, <fpage>0986</fpage>–<lpage>0997</lpage>. (<pub-id pub-id-type="doi">10.1371/journal.pbio.0030189</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shcherbik</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lapik</surname><given-names>YR</given-names></name>, <name name-style="western"><surname>Srivastava</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pestov</surname><given-names>DG</given-names></name></person-group>
<year>2010</year>
<article-title>Polyadenylation and degradation of incomplete RNA polymerase I transcripts in mammalian cells</article-title>. <source/>EMBO Rep.
<volume>11</volume>, <fpage>106</fpage>–<lpage>111</lpage>. (<pub-id pub-id-type="doi">10.1038/embor.2009.271</pub-id>)<pub-id pub-id-type="pmid">20062005</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fasken</surname><given-names>MB</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Air1 zinc knuckles 4 and 5 and a conserved IWRXY motif are critical for the function and integrity of the Trf4/5-Air1/2-Mtr4 polyadenylation (TRAMP) RNA quality control complex</article-title>. <source/>J. Biol. Chem.
<volume>286</volume>, <fpage>37 429</fpage>–<lpage>37 445</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.M111.271494</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudo</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nozaki</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Uno</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ishida</surname><given-names>Y ichi</given-names></name>, <name name-style="western"><surname>Nagahama</surname><given-names>M</given-names></name></person-group>
<year>2016</year>
<article-title>Interaction properties of human TRAMP-like proteins and their role in pre-rRNA 5′ETS turnover</article-title>. <source/>FEBS Lett.
<volume>590</volume>, <fpage>2963</fpage>–<lpage>2972</lpage>. (<pub-id pub-id-type="doi">10.1002/1873-3468.12314</pub-id>)<pub-id pub-id-type="pmid">27434818</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weick</surname><given-names>E-M</given-names></name>, <name name-style="western"><surname>Puno</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Januszyk</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zinder</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Dimattia</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Lima</surname><given-names>CD</given-names></name></person-group>
<year>2018</year>
<article-title>Helicase-dependent RNA decay illuminated by a cryo-EM structure of a human nuclear RNA exosome-MTR4 complex</article-title>. <source/>Cell
<volume>173</volume>, <fpage>1</fpage>–<lpage>15</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2018.03.012</pub-id>)<pub-id pub-id-type="pmid">29570990</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sloan</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Bohnsack</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Watkins</surname><given-names>NJ</given-names></name></person-group>
<year>2014</year>
<article-title>The roles of SSU processome components and surveillance factors in the initial processing of human ribosomal RNA</article-title>. <source/>RNA
<volume>20</volume>, <fpage>540</fpage>–<lpage>550</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.043471.113</pub-id>)<pub-id pub-id-type="pmid">24550520</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barandun</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hunziker</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Klinge</surname><given-names>S</given-names></name></person-group>
<year>2018</year>
<article-title>Assembly and structure of the SSU processome—a nucleolar precursor of the small ribosomal subunit</article-title>. <source/>Curr. Opin. Struct. Biol.
<volume>49</volume>, <fpage>1</fpage>–<lpage>9</lpage>. (<pub-id pub-id-type="doi">10.1016/j.sbi.2018.01.008</pub-id>)<pub-id pub-id-type="pmid">29132080</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sinturel</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Gerber</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mauvoisin</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gatfield</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Stubblefield</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Green</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Gachon</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Schibler</surname><given-names>U</given-names></name></person-group>
<year>2017</year>
<article-title>Diurnal oscillations in liver mass and cell size accompany ribosome assembly cycles</article-title>. <source/>Cell
<volume>169</volume>, <fpage>651</fpage>–<lpage>663.e14</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2017.04.015</pub-id>)<pub-id pub-id-type="pmid">28475894</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berndt</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Maturation of mammalian H/ACA box snoRNAs: PAPD5-dependent adenylation and PARN-dependent trimming</article-title>. <source/>RNA
<volume>18</volume>, <fpage>958</fpage>–<lpage>972</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.032292.112</pub-id>)<pub-id pub-id-type="pmid">22442037</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burroughs</surname><given-names>AM</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>A comprehensive survey of 3′ animal miRNA modification events and a possible role for 3′ adenylation in modulating miRNA targeting effectiveness</article-title>. <source/>Genome Res.
<volume>20</volume>, <fpage>1398</fpage>–<lpage>1410</lpage>. (<pub-id pub-id-type="doi">10.1101/gr.106054.110</pub-id>)<pub-id pub-id-type="pmid">20719920</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boele</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>PAPD5-mediated 3′ adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>111</volume>, <fpage>11 467</fpage>–<lpage>11 472</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1317751111</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newie</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Søkilde</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Persson</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Jacomasso</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Gorbatenko</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Borg</surname><given-names>Å</given-names></name>, <name name-style="western"><surname>De Hoon</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pedersen</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Rovira</surname><given-names>C</given-names></name></person-group>
<year>2016</year>
<article-title>HER2-encoded mir-4728 forms a receptor-independent circuit with miR-21-5p through the non-canonical poly(A) polymerase PAPD5</article-title>. <source/>Sci. Rep.
<volume>6</volume>, <fpage>35664</fpage> (<pub-id pub-id-type="doi">10.1038/srep35664</pub-id>)<pub-id pub-id-type="pmid">27752128</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shukla</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Goldfarb</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Cech</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>R</given-names></name></person-group>
<year>2016</year>
<article-title>Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>23</volume>, <fpage>286</fpage>–<lpage>292</lpage>. (<pub-id pub-id-type="doi">10.1038/nsmb.3184</pub-id>)<pub-id pub-id-type="pmid">26950371</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C73">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shukla</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>R</given-names></name></person-group>
<year>2017</year>
<article-title>PARN modulates Y RNA stability, 3′ end formation and its modification</article-title>. <source/>Mol. Cell. Biol.
<volume>37</volume>, <fpage>MCB.00264-17</fpage> (<pub-id pub-id-type="doi">10.1128/MCB.00264-17</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kowalski</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Krude</surname><given-names>T</given-names></name></person-group>
<year>2015</year>
<article-title>Functional roles of non-coding Y RNAs</article-title>. <source/>Int. J. Biochem. Cell Biol.
<volume>66</volume>, <fpage>20</fpage>–<lpage>29</lpage>. (<pub-id pub-id-type="doi">10.1016/j.biocel.2015.07.003</pub-id>)<pub-id pub-id-type="pmid">26159929</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Son</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>VN</given-names></name></person-group>
<year>2018</year>
<article-title>PARN and TOE1 constitute a 3′ end maturation module for nuclear non-coding RNAs</article-title>. <source/>Cell Rep.
<volume>23</volume>, <fpage>888</fpage>–<lpage>898</lpage>. (<pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.089</pub-id>)<pub-id pub-id-type="pmid">29669292</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C76">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burns</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>D'Ambrogio</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nottrott</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name></person-group>
<year>2011</year>
<article-title>CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation</article-title>. <source/>Nature
<volume>473</volume>, <fpage>105</fpage>–<lpage>108</lpage>. (<pub-id pub-id-type="doi">10.1038/nature09908</pub-id>)<pub-id pub-id-type="pmid">21478871</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C77">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Paek</surname><given-names>KY</given-names></name>, <name name-style="western"><surname>Ivshina</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stackpole</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name></person-group>
<year>2017</year>
<article-title>Essential role for non-canonical poly(A) polymerase GLD4 in cytoplasmic polyadenylation and carbohydrate metabolism</article-title>. <source/>Nucleic Acids Res.
<volume>45</volume>, <fpage>6793</fpage>–<lpage>6804</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkx239</pub-id>)<pub-id pub-id-type="pmid">28383716</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C78">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Webster</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Stowell</surname><given-names>JAW</given-names></name>, <name name-style="western"><surname>Alhusaini</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sweet</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Graveley</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Coller</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Passmore</surname><given-names>LA</given-names></name></person-group>
<year>2018</year>
<article-title>mRNA deadenylation is coupled to translation rates by the differential activities of Ccr4-Not nucleases</article-title>. <source/>Mol. Cell
<volume>70</volume>, <fpage>1089</fpage>–<lpage>1100</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2018.05.033</pub-id>)<pub-id pub-id-type="pmid">29932902</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C79">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ha</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>VN</given-names></name></person-group>
<year>2018</year>
<article-title>PABP cooperates with the CCR4-NOT complex to promote mRNA deadenylation and block precocious decay</article-title>. <source/>Mol. Cell
<volume>70</volume>, <fpage>1081</fpage>–<lpage>1088</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2018.05.009</pub-id>)<pub-id pub-id-type="pmid">29932901</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C80">
<label>80</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horvat</surname><given-names>F</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>Role of Cnot6l in maternal mRNA turnover</article-title>. <source/>Life Sci. Alliance
<volume>1</volume>, <fpage>e201800084</fpage> (<pub-id pub-id-type="doi">10.26508/lsa.201800084</pub-id>)<pub-id pub-id-type="pmid">30456367</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C81">
<label>81</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuchta</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Muszewska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Knizewski</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Steczkiewicz</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wyrwicz</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Pawlowski</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Rychlewski</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ginalski</surname><given-names>K</given-names></name></person-group>
<year>2016</year>
<article-title>FAM46 proteins are novel eukaryotic non-canonical poly(A) polymerases</article-title>. <source/>Nucleic Acids Res.
<volume>44</volume>, <fpage>3534</fpage>–<lpage>3548</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkw222</pub-id>)<pub-id pub-id-type="pmid">27060136</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C82">
<label>82</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mroczek</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma</article-title>. <source/>Nat. Commun.
<volume>8</volume>, <fpage>619</fpage> (<pub-id pub-id-type="doi">10.1038/s41467-017-00578-5</pub-id>)<pub-id pub-id-type="pmid">28931820</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C83">
<label>83</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barragán</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Borrego</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Abd El-Aziz</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>El-Ashry</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Abu-Safieh</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bhattacharya</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Antiñolo</surname><given-names>G</given-names></name></person-group>
<year>2008</year>
<article-title>Genetic analysis of FAM46A in Spanish families with autosomal recessive retinitis pigmentosa: characterisation of novel VNTRs</article-title>. <source/>Ann. Hum. Genet.
<volume>72</volume>, <fpage>26</fpage>–<lpage>34</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1469-1809.2007.00393.x</pub-id>)<pub-id pub-id-type="pmid">17803723</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C84">
<label>84</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lagali</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Kakuk</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Griesinger</surname><given-names>IB</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Ayyagari</surname><given-names>R</given-names></name></person-group>
<year>2002</year>
<article-title>Identification and characterization of <italic>C6orf37</italic>, a novel candidate human retinal disease gene on chromosome 6q14</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>293</volume>, <fpage>356</fpage>–<lpage>365</lpage>. (<pub-id pub-id-type="doi">10.1016/S0006-291X(02)00228-0</pub-id>)<pub-id pub-id-type="pmid">12054608</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C85">
<label>85</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schulz</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Goetz</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kaschkoetoe</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>BHF</given-names></name></person-group>
<year>2004</year>
<article-title>The retinome—defining a reference transcriptome of the adult mammalian retina/retinal pigment epithelium</article-title>. <source/>BMC Genomics
<volume>5</volume>, <fpage>50</fpage> (<pub-id pub-id-type="doi">10.1186/1471-2164-5-50</pub-id>)<pub-id pub-id-type="pmid">15283859</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C86">
<label>86</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Etokebe</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Küchler</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Haraldsen</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Landin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Osmundsen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Dembic</surname><given-names>Z</given-names></name></person-group>
<year>2009</year>
<article-title>Family-with-sequence-similarity-46, member A (Fam46a) gene is expressed in developing tooth buds</article-title>. <source/>Arch. Oral Biol.
<volume>54</volume>, <fpage>1002</fpage>–<lpage>1007</lpage>. (<pub-id pub-id-type="doi">10.1016/j.archoralbio.2009.08.005</pub-id>)<pub-id pub-id-type="pmid">19740458</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C87">
<label>87</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Etokebe</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Jotanovic</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Mihelic</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Jericevic</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Nikolic</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Balen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sestan</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Dembic</surname><given-names>Z</given-names></name></person-group>
<year>2015</year>
<article-title>Susceptibility to large-joint osteoarthritis (hip and knee) is associated with BAG6 rs3117582 SNP and the VNTR polymorphism in the second exon of the FAM46A gene on chromosome 6</article-title>. <source/>J. Orthop. Res.
<volume>33</volume>, <fpage>56</fpage>–<lpage>62</lpage>. (<pub-id pub-id-type="doi">10.1002/jor.22738</pub-id>)<pub-id pub-id-type="pmid">25231575</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C88">
<label>88</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diener</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Exome sequencing identifies a nonsense mutation in <italic>Fam46a</italic> associated with bone abnormalities in a new mouse model for skeletal dysplasia</article-title>. <source/>Mamm. Genome
<volume>27</volume>, <fpage>111</fpage>–<lpage>121</lpage>. (<pub-id pub-id-type="doi">10.1007/s00335-016-9619-x</pub-id>)<pub-id pub-id-type="pmid">26803617</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C89">
<label>89</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doyard</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title><italic>FAM46A</italic> mutations are responsible for autosomal recessive osteogenesis imperfecta</article-title>. <source/>J. Med. Genet.
<volume>55</volume>, <fpage>278</fpage>–<lpage>284</lpage>. (<pub-id pub-id-type="doi">10.1136/jmedgenet-2017-104999</pub-id>)<pub-id pub-id-type="pmid">29358272</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C90">
<label>90</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benjachat</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>Biomarkers for refractory lupus nephritis: a microarray study of kidney tissue</article-title>. <source/>Int. J. Mol. Sci.
<volume>16</volume>, <fpage>14 276</fpage>–<lpage>14 290</lpage>. (<pub-id pub-id-type="doi">10.3390/ijms160614276</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C91">
<label>91</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chapman</surname><given-names>MA</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Initial genome sequencing and analysis of multiple myeloma</article-title>. <source/>Nature
<volume>471</volume>, <fpage>467</fpage>–<lpage>472</lpage>. (<pub-id pub-id-type="doi">10.1038/nature09837</pub-id>)<pub-id pub-id-type="pmid">21430775</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C92">
<label>92</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyd</surname><given-names>KD</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Mapping of chromosome 1p deletions in myeloma identifies <italic>FAM46C</italic> at 1p12 and <italic>CDKN2C</italic> at 1p32.3 as being genes in regions associated with adverse survival</article-title>. <source/>Clin. Cancer Res.
<volume>17</volume>, <fpage>7776</fpage>–<lpage>7784</lpage>. (<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-11-1791</pub-id>)<pub-id pub-id-type="pmid">21994415</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C93">
<label>93</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lohr</surname><given-names>JG</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>Widespread genetic heterogeneity in multiple myeloma: Implications for targeted therapy</article-title>. <source/>Cancer Cell
<volume>25</volume>, <fpage>91</fpage>–<lpage>101</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ccr.2013.12.015</pub-id>)<pub-id pub-id-type="pmid">24434212</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C94">
<label>94</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barbieri</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Compendium of <italic>FAM46C</italic> gene mutations in plasma cell dyscrasias</article-title>. <source/>Br. J. Haematol.
<volume>174</volume>, <fpage>642</fpage>–<lpage>645</lpage>. (<pub-id pub-id-type="doi">10.1111/bjh.13793</pub-id>)<pub-id pub-id-type="pmid">26456599</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C95">
<label>95</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>YX</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>Loss of FAM46C promotes cell survival in myeloma</article-title>. <source/>Cancer Res.
<volume>77</volume>, <fpage>4317</fpage>–<lpage>4327</lpage>. (<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-16-3011</pub-id>)<pub-id pub-id-type="pmid">28619709</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C96">
<label>96</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dickinson</surname><given-names>ME</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>High-throughput discovery of novel developmental phenotypes</article-title>. <source/>Nature
<volume>537</volume>, <fpage>508</fpage>–<lpage>514</lpage>. (<pub-id pub-id-type="doi">10.1038/nature19356</pub-id>)<pub-id pub-id-type="pmid">27626380</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C97">
<label>97</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanaka</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title><italic>FAM46C</italic> serves as a predictor of hepatic recurrence in patients with resectable gastric cancer</article-title>. <source/>Ann. Surg. Oncol.
<volume>24</volume>, <fpage>3438</fpage>–<lpage>3445</lpage>. (<pub-id pub-id-type="doi">10.1245/s10434-016-5636-y</pub-id>)<pub-id pub-id-type="pmid">27770343</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C98">
<label>98</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname><given-names>XY</given-names></name>, <name name-style="western"><surname>Zhai</surname><given-names>XF</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>YP</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>QY</given-names></name>, <name name-style="western"><surname>Xin</surname><given-names>HL</given-names></name></person-group>
<year>2017</year>
<article-title>Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression</article-title>. <source/>Am. J. Transl. Res.
<volume>9</volume>, <fpage>155</fpage>–<lpage>166</lpage>.<pub-id pub-id-type="pmid">28123642</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C99">
<label>99</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>QY</given-names></name>, <name name-style="western"><surname>Yue</surname><given-names>XQ</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>YP</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Xin</surname><given-names>HL</given-names></name></person-group>
<year>2017</year>
<article-title>FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells</article-title>. <source/>Sci. Rep.
<volume>7</volume>, <fpage>396</fpage> (<pub-id pub-id-type="doi">10.1038/s41598-017-00313-6</pub-id>)<pub-id pub-id-type="pmid">28341836</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C100">
<label>100</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamilton</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Spencer</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Harrison</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>Yuva-Paylor</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Graham</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Daza</surname><given-names>RAM</given-names></name>, <name name-style="western"><surname>Hevner</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Overbeek</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Paylor</surname><given-names>R</given-names></name></person-group>
<year>2011</year>
<article-title>Multiple autism-like behaviors in a novel transgenic mouse model</article-title>. <source/>Behav. Brain Res.
<volume>218</volume>, <fpage>29</fpage>–<lpage>41</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbr.2010.11.026</pub-id>)<pub-id pub-id-type="pmid">21093492</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C101">
<label>101</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bettoni</surname><given-names>F</given-names></name><etal>et al.</etal></person-group>
<year>2009</year>
<article-title>Identification of FAM46D as a novel cancer/testis antigen using EST data and serological analysis</article-title>. <source/>Genomics
<volume>94</volume>, <fpage>153</fpage>–<lpage>160</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ygeno.2009.06.001</pub-id>)<pub-id pub-id-type="pmid">19540335</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C102">
<label>102</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagaike</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Katoh</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ueda</surname><given-names>T</given-names></name></person-group>
<year>2005</year>
<article-title>Human mitochondrial mRNAs are stabilized with polyadenylation regulated by mitochondria-specific poly(A) polymerase and polynucleotide phosphorylase</article-title>. <source/>J. Biol. Chem.
<volume>280</volume>, <fpage>19 721</fpage>–<lpage>19 727</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.M500804200</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C103">
<label>103</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomecki</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dmochowska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gewartowski</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Dziembowski</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Stepien</surname><given-names>PP</given-names></name></person-group>
<year>2004</year>
<article-title>Identification of a novel human nuclear-encoded mitochondrial poly(A) polymerase</article-title>. <source/>Nucleic Acids Res.
<volume>32</volume>, <fpage>6001</fpage>–<lpage>6014</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkh923</pub-id>)<pub-id pub-id-type="pmid">15547249</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C104">
<label>104</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Srivastava</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Manley</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>L</given-names></name></person-group>
<year>2011</year>
<article-title>Structural basis for dimerization and activity of human PAPD1, a noncanonical poly(A) polymerase</article-title>. <source/>Mol. Cell
<volume>41</volume>, <fpage>311</fpage>–<lpage>320</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2011.01.013</pub-id>)<pub-id pub-id-type="pmid">21292163</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C105">
<label>105</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chujo</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ohira</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sakaguchi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Goshima</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Nomura</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Nagao</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name></person-group>
<year>2012</year>
<article-title>LRPPRC/SLIRP suppresses PNPase-mediated mRNA decay and promotes polyadenylation in human mitochondria</article-title>. <source/>Nucleic Acids Res.
<volume>40</volume>, <fpage>8033</fpage>–<lpage>8047</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gks506</pub-id>)<pub-id pub-id-type="pmid">22661577</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C106">
<label>106</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>WC</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>A human mitochondrial poly(A) polymerase mutation reveals the complexities of post-transcriptional mitochondrial gene expression</article-title>. <source/>Hum. Mol. Genet.
<volume>23</volume>, <fpage>6345</fpage>–<lpage>6355</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/ddu352</pub-id>)<pub-id pub-id-type="pmid">25008111</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C107">
<label>107</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>DDH</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>XE</given-names></name>, <name name-style="western"><surname>Modrek</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>PL</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>WH</given-names></name></person-group>
<year>2014</year>
<article-title>Helicase SUV3, polynucleotide phosphorylase, and mitochondrial polyadenylation polymerase form a transient complex to modulate mitochondrial mRNA polyadenylated tail lengths in response to energetic changes</article-title>. <source/>J. Biol. Chem.
<volume>289</volume>, <fpage>16 727</fpage>–<lpage>16 735</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.M113.536540</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C108">
<label>108</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borowski</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Szczesny</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Brzezniak</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Stepien</surname><given-names>PP</given-names></name></person-group>
<year>2010</year>
<article-title>RNA turnover in human mitochondria: more questions than answers?</article-title>
<source/>Biochim. Biophys. Acta Bioenerg.
<volume>1797</volume>, <fpage>1066</fpage>–<lpage>1070</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbabio.2010.01.028</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C109">
<label>109</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gagliardi</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Stepien</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Temperley</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Lightowlers</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>Chrzanowska-Lightowlers</surname><given-names>ZMA</given-names></name></person-group>
<year>2004</year>
<article-title>Messenger RNA stability in mitochondria: different means to an end</article-title>. <source/>Trends Genet.
<volume>20</volume>, <fpage>260</fpage>–<lpage>267</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tig.2004.04.006</pub-id>)<pub-id pub-id-type="pmid">15145579</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C110">
<label>110</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagaike</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ueda</surname><given-names>T</given-names></name></person-group>
<year>2008</year>
<article-title>Polyadenylation in mammalian mitochondria: insights from recent studies</article-title>. <source/>Biochim. Biophys. Acta Gene Regul. Mech.
<volume>1779</volume>, <fpage>266</fpage>–<lpage>269</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbagrm.2008.02.001</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C111">
<label>111</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fiedler</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rossmanith</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wahle</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rammelt</surname><given-names>C</given-names></name></person-group>
<year>2015</year>
<article-title>Mitochondrial poly(A) polymerase is involved in tRNA repair</article-title>. <source/>Nucleic Acids Res.
<volume>43</volume>, <fpage>9937</fpage>–<lpage>9949</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkv891</pub-id>)<pub-id pub-id-type="pmid">26354863</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C112">
<label>112</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pearce</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Rorbach</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Van Haute</surname><given-names>L</given-names></name>, <name name-style="western"><surname>D'Souza</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Rebelo-Guiomar</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Powell</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Brierley</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Firth</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Minczuk</surname><given-names>M</given-names></name></person-group>
<year>2017</year>
<article-title>Maturation of selected human mitochondrial tRNAs requires deadenylation</article-title>. <source/>Elife
<volume>6</volume>, <fpage>e27596</fpage> (<pub-id pub-id-type="doi">10.7554/eLife.27596</pub-id>)<pub-id pub-id-type="pmid">28745585</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C113">
<label>113</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wyman</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Knouf</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Parkin</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Fritz</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Dennis</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Krouse</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Webster</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Tewari</surname><given-names>M</given-names></name></person-group>
<year>2011</year>
<article-title>Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity</article-title>. <source/>Genome Res.
<volume>21</volume>, <fpage>1450</fpage>–<lpage>1461</lpage>. (<pub-id pub-id-type="doi">10.1101/gr.118059.110</pub-id>)<pub-id pub-id-type="pmid">21813625</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C114">
<label>114</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crosby</surname><given-names>AH</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>Defective mitochondrial mRNA maturation is associated with spastic ataxia</article-title>. <source/>Am. J. Hum. Genet.
<volume>87</volume>, <fpage>655</fpage>–<lpage>660</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.09.013</pub-id>)<pub-id pub-id-type="pmid">20970105</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C115">
<label>115</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>NT</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>Homozygous mutation of MTPAP causes cellular radiosensitivity and persistent DNA double-strand breaks</article-title>. <source/>Cell Death Dis.
<volume>5</volume>, <fpage>e1130</fpage> (<pub-id pub-id-type="doi">10.1038/cddis.2014.99</pub-id>)<pub-id pub-id-type="pmid">24651433</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C116">
<label>116</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Michal</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Reeves</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Busboom</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Thorgaard</surname><given-names>GH</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Z</given-names></name></person-group>
<year>2006</year>
<article-title>A novel nuclear-encoded mitochondrial poly(A) polymerase <italic>PAPD1</italic> is a potential candidate gene for the extreme obesity related phenotypes in mammals</article-title>. <source/>Int. J. Biol. Sci.
<volume>2</volume>, <fpage>171</fpage>–<lpage>178</lpage>. (<pub-id pub-id-type="doi">10.7150/ijbs.2.171</pub-id>)<pub-id pub-id-type="pmid">16810331</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C117">
<label>117</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zigáčková</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Vaňáčová</surname><given-names>S.</given-names></name></person-group>
<year>2018</year>
<article-title>The role of 3' end uridylation in RNA metabolism and cellular physiology</article-title>. <source/>Phil. Trans. R. Soc. B
<volume>373</volume>, <fpage>20180171</fpage> (<pub-id pub-id-type="doi">10.1098/rstb.2018.0171</pub-id>)<pub-id pub-id-type="pmid">30397107</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C118">
<label>118</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Almeida</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Scheer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gobert</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fileccia</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Martinelli</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zuber</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gagliardi</surname><given-names>D.</given-names></name></person-group>
<year>2018</year>
<article-title>RNA uridylation and decay in plants</article-title>. <source/>Phil. Trans. R. Soc. B
<volume>373</volume>, <fpage>20180163</fpage> (<pub-id pub-id-type="doi">10.1098/rstb.2018.0163</pub-id>)<pub-id pub-id-type="pmid">30397100</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C119">
<label>119</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trippe</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Guschina</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hossbach</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Urlaub</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lührmann</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Benecke</surname><given-names>BJ</given-names></name></person-group>
<year>2006</year>
<article-title>Identification, cloning, and functional analysis of the human U6 snRNA-specific terminal uridylyl transferase</article-title>. <source/>RNA
<volume>12</volume>, <fpage>1494</fpage>–<lpage>1504</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.87706</pub-id>)<pub-id pub-id-type="pmid">16790842</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C120">
<label>120</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uhlen</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>Tissue-based map of the human proteome</article-title>. <source/>Science
<volume>347</volume>, <fpage>1260419</fpage> (<pub-id pub-id-type="doi">10.1126/science.1260419</pub-id>)<pub-id pub-id-type="pmid">25613900</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C121">
<label>121</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blomen</surname><given-names>VA</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>Gene essentiality and synthetic lethality in haploid human cells</article-title>. <source/>Science
<volume>350</volume>, <fpage>1092</fpage>–<lpage>1096</lpage>. (<pub-id pub-id-type="doi">10.1126/science.aac7557</pub-id>)<pub-id pub-id-type="pmid">26472760</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C122">
<label>122</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>XM</given-names></name>, <name name-style="western"><surname>Bork</surname><given-names>P</given-names></name></person-group>
<year>2017</year>
<article-title>OGEE v2: an update of the online gene essentiality database with special focus on differentially essential genes in human cancer cell lines</article-title>. <source/>Nucleic Acids Res.
<volume>45</volume>, <fpage>D940</fpage>–<lpage>D944</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkw1013</pub-id>)<pub-id pub-id-type="pmid">27799467</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C123">
<label>123</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hart</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities</article-title>. <source/>Cell
<volume>163</volume>, <fpage>1515</fpage>–<lpage>1526</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2015.11.015</pub-id>)<pub-id pub-id-type="pmid">26627737</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C124">
<label>124</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Birsoy</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hughes</surname><given-names>NW</given-names></name>, <name name-style="western"><surname>Krupczak</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Post</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Lander</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2015</year>
<article-title>Identification and characterization of essential genes in the human genome</article-title>. <source/>Science
<volume>350</volume>, <fpage>1096</fpage>–<lpage>1101</lpage>. (<pub-id pub-id-type="doi">10.1126/science.aac7041</pub-id>)<pub-id pub-id-type="pmid">26472758</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C125">
<label>125</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Tsuruta</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Okajima</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yano</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sato</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Chiba</surname><given-names>T</given-names></name></person-group>
<year>2017</year>
<article-title>KLHL7 promotes TUT1 ubiquitination associated with nucleolar integrity: implications for retinitis pigmentosa</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>494</volume>, <fpage>220</fpage>–<lpage>226</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbrc.2017.10.049</pub-id>)<pub-id pub-id-type="pmid">29032201</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C126">
<label>126</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mellman</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Gonzales</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Barlow</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kendziorski</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>RA</given-names></name></person-group>
<year>2008</year>
<article-title>A PtdIns4,5P2-regulated nuclear poly(A) polymerase controls expression of select mRNAs</article-title>. <source/>Nature
<volume>451</volume>, <fpage>1013</fpage>–<lpage>1017</lpage>. (<pub-id pub-id-type="doi">10.1038/nature06666</pub-id>)<pub-id pub-id-type="pmid">18288197</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C127">
<label>127</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faehnle</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Walleshauser</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Joshua-Tor</surname><given-names>L</given-names></name></person-group>
<year>2017</year>
<article-title>Multi-domain utilization by TUT4 and TUT7 in control of let-7 biogenesis</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>24</volume>, <fpage>658</fpage>–<lpage>665</lpage>. (<pub-id pub-id-type="doi">10.1038/nsmb.3428</pub-id>)<pub-id pub-id-type="pmid">28671666</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C128">
<label>128</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamashita</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Takagi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nagaike</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tomita</surname><given-names>K</given-names></name></person-group>
<year>2017</year>
<article-title>Crystal structures of U6 snRNA-specific terminal uridylyltransferase</article-title>. <source/>Nat. Commun.
<volume>8</volume>, <fpage>15788</fpage> (<pub-id pub-id-type="doi">10.1038/ncomms15788</pub-id>)<pub-id pub-id-type="pmid">28589955</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C129">
<label>129</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laishram</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>RA</given-names></name></person-group>
<year>2010</year>
<article-title>The poly A polymerase Star-PAP controls 3′-end cleavage by promoting CPSF interaction and specificity toward the pre-mRNA</article-title>. <source/>EMBO J.
<volume>29</volume>, <fpage>4132</fpage>–<lpage>4145</lpage>. (<pub-id pub-id-type="doi">10.1038/emboj.2010.287</pub-id>)<pub-id pub-id-type="pmid">21102410</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C130">
<label>130</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonzales</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Mellman</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>RA</given-names></name></person-group>
<year>2008</year>
<article-title>CKIα is associated with and phosphorylates Star-PAP and is also required for expression of select Star-PAP target messenger RNAs</article-title>. <source/>J. Biol. Chem.
<volume>283</volume>, <fpage>12 665</fpage>–<lpage>12 673</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.M800656200</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C131">
<label>131</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Doublié</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Keller</surname><given-names>W</given-names></name></person-group>
<year>2008</year>
<article-title>Determinants of substrate specificity in RNA-dependent nucleotidyl transferases</article-title>. <source/>Biochim. Biophys. Acta Gene Regul. Mech.
<volume>1779</volume>, <fpage>206</fpage>–<lpage>216</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbagrm.2007.12.003</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C132">
<label>132</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trippe</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Richly</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Benecke</surname><given-names>BJ</given-names></name></person-group>
<year>2003</year>
<article-title>Biochemical characterization of a U6 small nuclear RNA-specific terminal uridylyltransferase</article-title>. <source/>Eur. J. Biochem.
<volume>270</volume>, <fpage>971</fpage>–<lpage>980</lpage>. (<pub-id pub-id-type="doi">10.1046/j.1432-1033.2003.03466.x</pub-id>)<pub-id pub-id-type="pmid">12603330</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C133">
<label>133</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirai</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Natori</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sekimizu</surname><given-names>K</given-names></name></person-group>
<year>1988</year>
<article-title>Uridylation of U6 RNA in a nuclear extract in Ehrlich ascites tumor cells</article-title>. <source/>J. Biochem.
<volume>104</volume>, <fpage>991</fpage>–<lpage>994</lpage>. (<pub-id pub-id-type="doi">10.1093/oxfordjournals.jbchem.a122597</pub-id>)<pub-id pub-id-type="pmid">3243771</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C134">
<label>134</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lund</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Dahlberg</surname><given-names>JE</given-names></name></person-group>
<year>1992</year>
<article-title>Cyclic 2′,3′-phosphates and nontemplated nucleotides at the 3′ end of spliceosomal U6 small nuclear RNA's</article-title>. <source/>Science
<volume>255</volume>, <fpage>327</fpage>–<lpage>330</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1549778</pub-id>)<pub-id pub-id-type="pmid">1549778</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C135">
<label>135</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Didychuk</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Montemayor</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Carrocci</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Delaitsch</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Lucarelli</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Westler</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Brow</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Hoskins</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Butcher</surname><given-names>SE</given-names></name></person-group>
<year>2017</year>
<article-title>Usb1 controls U6 snRNP assembly through evolutionarily divergent cyclic phosphodiesterase activities</article-title>. <source/>Nat. Commun.
<volume>8</volume>, <fpage>497</fpage> (<pub-id pub-id-type="doi">10.1038/s41467-017-00484-w</pub-id>)<pub-id pub-id-type="pmid">28887445</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C136">
<label>136</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mroczek</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Krwawicz</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kutner</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lazniewski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kuciński</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Ginalski</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Dziembowski</surname><given-names>A</given-names></name></person-group>
<year>2012</year>
<article-title><italic>C16orf57</italic>, a gene mutated in poikiloderma with neutropenia, encodes a putative phosphodiesterase responsible for the U6 snRNA 3′ end modification</article-title>. <source/>Genes Dev.
<volume>26</volume>, <fpage>1911</fpage>–<lpage>1925</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.193169.112</pub-id>)<pub-id pub-id-type="pmid">22899009</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C137">
<label>137</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mroczek</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dziembowski</surname><given-names>A</given-names></name></person-group>
<year>2013</year>
<article-title>U6 RNA biogenesis and disease association</article-title>. <source/>Wiley Interdiscip. Rev. RNA
<volume>4</volume>, <fpage>581</fpage>–<lpage>592</lpage>. (<pub-id pub-id-type="doi">10.1002/wrna.1181</pub-id>)<pub-id pub-id-type="pmid">23776162</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C138">
<label>138</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shchepachev</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Wischnewski</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Missiaglia</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Soneson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Azzalin</surname><given-names>CM</given-names></name></person-group>
<year>2012</year>
<article-title>Mpn1, mutated in poikiloderma with neutropenia protein 1, is a conserved 3′-to-5′ RNA exonuclease processing U6 small nuclear RNA</article-title>. <source/>Cell Rep.
<volume>2</volume>, <fpage>855</fpage>–<lpage>865</lpage>. (<pub-id pub-id-type="doi">10.1016/j.celrep.2012.08.031</pub-id>)<pub-id pub-id-type="pmid">23022480</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C139">
<label>139</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shchepachev</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Wischnewski</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Soneson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Arnold</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Azzalin</surname><given-names>CM</given-names></name></person-group>
<year>2015</year>
<article-title>Human Mpn1 promotes post-transcriptional processing and stability of U6atac</article-title>. <source/>FEBS Lett.
<volume>589</volume>, <fpage>2417</fpage>–<lpage>2423</lpage>. (<pub-id pub-id-type="doi">10.1016/j.febslet.2015.06.046</pub-id>)<pub-id pub-id-type="pmid">26213367</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C140">
<label>140</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Łabno</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Warkocki</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Kulinski</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Krawczyk</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Bijata</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tomecki</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dziembowski</surname><given-names>A</given-names></name></person-group>
<year>2016</year>
<article-title>Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs</article-title>. <source/>Nucleic Acids Res.
<volume>44</volume>, <fpage>10 437</fpage>–<lpage>10 453</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkw649</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C141">
<label>141</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Achsel</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Brahms</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kastner</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bachi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wilm</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lührmann</surname><given-names>R</given-names></name></person-group>
<year>1999</year>
<article-title>A doughnut-shaped heteromer of human Sm-like proteins binds to the 3′-end of U6 snRNA, thereby facilitating U4/U6 duplex formation <italic>in vitro</italic></article-title>. <source/>EMBO J.
<volume>18</volume>, <fpage>5789</fpage>–<lpage>5802</lpage>. (<pub-id pub-id-type="doi">10.1093/emboj/18.20.5789</pub-id>)<pub-id pub-id-type="pmid">10523320</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C142">
<label>142</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karaduman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dube</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Stark</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fabrizio</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kastner</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lührmann</surname><given-names>R</given-names></name></person-group>
<year>2008</year>
<article-title>Structure of yeast U6 snRNPs: Arrangement of Prp24p and the LSm complex as revealed by electron microscopy</article-title>. <source/>RNA
<volume>14</volume>, <fpage>2528</fpage>–<lpage>2537</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.1369808</pub-id>)<pub-id pub-id-type="pmid">18971323</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C143">
<label>143</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raghunathan</surname><given-names>PL</given-names></name>, <name name-style="western"><surname>Guthrie</surname><given-names>C</given-names></name></person-group>
<year>1998</year>
<article-title>A spliceosomal recycling factor that reanneals U4 and U6 small nuclear ribonucleoprotein particles</article-title>. <source/>Science
<volume>279</volume>, <fpage>857</fpage>–<lpage>860</lpage>. (<pub-id pub-id-type="doi">10.1126/science.279.5352.857</pub-id>)<pub-id pub-id-type="pmid">9452384</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C144">
<label>144</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karaduman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fabrizio</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hartmuth</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Urlaub</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lührmann</surname><given-names>R</given-names></name></person-group>
<year>2006</year>
<article-title>RNA structure and RNA–protein interactions in purified yeast U6 snRNPs</article-title>. <source/>J. Mol. Biol.
<volume>356</volume>, <fpage>1248</fpage>–<lpage>1262</lpage>. (<pub-id pub-id-type="doi">10.1016/j.jmb.2005.12.013</pub-id>)<pub-id pub-id-type="pmid">16410014</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C145">
<label>145</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Laishram</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>RA</given-names></name></person-group>
<year>2013</year>
<article-title>The novel poly(A) polymerase Star-PAP is a signal-regulated switch at the 3′-end of mRNAs</article-title>. <source/>Adv. Biol. Regul.
<volume>53</volume>, <fpage>64</fpage>–<lpage>76</lpage>. (<pub-id pub-id-type="doi">10.1016/j.jbior.2012.10.004</pub-id>)<pub-id pub-id-type="pmid">23306079</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C146">
<label>146</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Laishram</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Barlow</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>RA</given-names></name></person-group>
<year>2012</year>
<article-title>Star-PAP control of BIK expression and apoptosis is regulated by nuclear PIPKIα and PKCδ signaling</article-title>. <source/>Mol. Cell
<volume>45</volume>, <fpage>25</fpage>–<lpage>37</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2011.11.017</pub-id>)<pub-id pub-id-type="pmid">22244330</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C147">
<label>147</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kandala</surname><given-names>DT</given-names></name>, <name name-style="western"><surname>Mohan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Vivekanand</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sudheesh</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Reshmi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Laishram</surname><given-names>RS</given-names></name></person-group>
<year>2015</year>
<article-title>CstF-64 and 3′-UTR cis-element determine Star-PAP specificity for target mRNA selection by excluding PAPα</article-title>. <source/>Nucleic Acids Res.
<volume>44</volume>, <fpage>811</fpage>–<lpage>823</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkv1074</pub-id>)<pub-id pub-id-type="pmid">26496945</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C148">
<label>148</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Laishram</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Hoque</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>RA</given-names></name></person-group>
<year>2017</year>
<article-title>Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases</article-title>. <source/>Nucleic Acids Res.
<volume>45</volume>, <fpage>8930</fpage>–<lpage>8942</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkx560</pub-id>)<pub-id pub-id-type="pmid">28911096</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C149">
<label>149</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Cetin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Messmer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chane-Woon-Ming</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Terenzi</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Chicher</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kuhn</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hammann</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pfeffer</surname><given-names>S</given-names></name></person-group>
<year>2016</year>
<article-title>Identification of factors involved in target RNA-directed microRNA degradation</article-title>. <source/>Nucleic Acids Res.
<volume>44</volume>, <fpage>2873</fpage>–<lpage>2887</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkw040</pub-id>)<pub-id pub-id-type="pmid">26809675</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C150">
<label>150</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knouf</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Wyman</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Tewari</surname><given-names>M</given-names></name></person-group>
<year>2013</year>
<article-title>The human TUT1 nucleotidyl transferase as a global regulator of microRNA abundance</article-title>. <source/>PLoS ONE
<volume>8</volume>, <fpage>e69630</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0069630</pub-id>)<pub-id pub-id-type="pmid">23874977</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C151">
<label>151</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>D qiu</given-names></name>, <name name-style="western"><surname>Lou</surname><given-names>Y fen</given-names></name>, <name name-style="western"><surname>He</surname><given-names>Z gao</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>M</given-names></name></person-group>
<year>2014</year>
<article-title>Nucleotidyl transferase TUT1 inhibits lipogenesis in osteosarcoma cells through regulation of microRNA-24 and microRNA-29a</article-title>. <source/>Tumor Biol.
<volume>35</volume>, <fpage>11 829</fpage>–<lpage>11 835</lpage>. (<pub-id pub-id-type="doi">10.1007/s13277-014-2395-x</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C152">
<label>152</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Modepalli</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>Y</given-names></name></person-group>
<year>2017</year>
<article-title>Evolution of miRNA tailing by 3′ terminal uridylyl transferases in Metazoa</article-title>. <source/>Genome Biol. Evol.
<volume>9</volume>, <fpage>1547</fpage>–<lpage>1560</lpage>. (<pub-id pub-id-type="doi">10.1093/gbe/evx106</pub-id>)<pub-id pub-id-type="pmid">28633361</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C153">
<label>153</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thornton</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>H-M</given-names></name>, <name name-style="western"><surname>Piskounova</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gregory</surname><given-names>RI</given-names></name></person-group>
<year>2012</year>
<article-title>Lin28-mediated control of let-7 microRNA expression by alternative TUTases Zcchc11 (TUT4) and Zcchc6 (TUT7)</article-title>. <source/>RNA
<volume>18</volume>, <fpage>1875</fpage>–<lpage>1885</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.034538.112</pub-id>)<pub-id pub-id-type="pmid">22898984</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C154">
<label>154</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masood</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Yasmin</surname><given-names>A</given-names></name></person-group>
<year>2017</year>
<article-title>Entangling relation of micro RNA-let7, miRNA-200 and miRNA-125 with various cancers</article-title>. <source/>Pathol. Oncol. Res.
<volume>23</volume>, <fpage>707</fpage>–<lpage>715</lpage>. (<pub-id pub-id-type="doi">10.1007/s12253-016-0184-0</pub-id>)<pub-id pub-id-type="pmid">28070818</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C155">
<label>155</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Urbich</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kuehbacher</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dimmeler</surname><given-names>S</given-names></name></person-group>
<year>2008</year>
<article-title>Role of microRNAs in vascular diseases, inflammation, and angiogenesis</article-title>. <source/>Cardiovasc. Res.
<volume>79</volume>, <fpage>581</fpage>–<lpage>588</lpage>. (<pub-id pub-id-type="doi">10.1093/cvr/cvn156</pub-id>)<pub-id pub-id-type="pmid">18550634</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C156">
<label>156</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiang</surname><given-names>HR</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>Mammalian microRNAs: experimental evaluation of novel and previously annotated genes</article-title>. <source/>Genes Dev.
<volume>24</volume>, <fpage>992</fpage>–<lpage>1009</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.1884710</pub-id>)<pub-id pub-id-type="pmid">20413612</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C157">
<label>157</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faehnle</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Walleshauser</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Joshua-Tor</surname><given-names>L</given-names></name></person-group>
<year>2014</year>
<article-title>Mechanism of Dis3l2 substrate recognition in the Lin28-let-7 pathway</article-title>. <source/>Nature
<volume>514</volume>, <fpage>252</fpage>–<lpage>256</lpage>. (<pub-id pub-id-type="doi">10.1038/nature13553</pub-id>)<pub-id pub-id-type="pmid">25119025</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C158">
<label>158</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagan</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Piskounova</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gregory</surname><given-names>RI</given-names></name></person-group>
<year>2009</year>
<article-title>Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>16</volume>, <fpage>1021</fpage>–<lpage>1025</lpage>. (<pub-id pub-id-type="doi">10.1038/nsmb.1676</pub-id>)<pub-id pub-id-type="pmid">19713958</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C159">
<label>159</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heo</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Joo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>YK</given-names></name>, <name name-style="western"><surname>Ha</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yeom</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>VN</given-names></name></person-group>
<year>2009</year>
<article-title>TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation</article-title>. <source/>Cell
<volume>138</volume>, <fpage>696</fpage>–<lpage>708</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2009.08.002</pub-id>)<pub-id pub-id-type="pmid">19703396</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C160">
<label>160</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heo</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Joo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ha</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>VN</given-names></name></person-group>
<year>2008</year>
<article-title>Lin28 mediates the terminal uridylation of let-7 precursor microRNA</article-title>. <source/>Mol. Cell
<volume>32</volume>, <fpage>276</fpage>–<lpage>284</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2008.09.014</pub-id>)<pub-id pub-id-type="pmid">18951094</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C161">
<label>161</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piskounova</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Polytarchou</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Thornton</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Lapierre</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Pothoulakis</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hagan</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Iliopoulos</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gregory</surname><given-names>RI</given-names></name></person-group>
<year>2011</year>
<article-title>Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms</article-title>. <source/>Cell
<volume>147</volume>, <fpage>1066</fpage>–<lpage>1079</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2011.10.039</pub-id>)<pub-id pub-id-type="pmid">22118463</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C162">
<label>162</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ustianenko</surname><given-names>D</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of let-7 miRNAs</article-title>. <source/>RNA
<volume>19</volume>, <fpage>1632</fpage>–<lpage>1638</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.040055.113</pub-id>)<pub-id pub-id-type="pmid">24141620</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C163">
<label>163</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nowak</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Hobor</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Velasco</surname><given-names>ADR</given-names></name>, <name name-style="western"><surname>Choudhury</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Heikel</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kerr</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ramos</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Michlewski</surname><given-names>G</given-names></name></person-group>
<year>2017</year>
<article-title>Lin28a uses distinct mechanisms of binding to RNA and affects miRNA levels positively and negatively</article-title>. <source/>RNA
<volume>23</volume>, <fpage>317</fpage>–<lpage>332</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.059196.116</pub-id>)<pub-id pub-id-type="pmid">27881476</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C164">
<label>164</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choudhury</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Nowak</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Zuo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rappsilber</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Spoel</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Michlewski</surname><given-names>G</given-names></name></person-group>
<year>2014</year>
<article-title>Trim25 is an RNA-specific activator of Lin28a/TuT4-mediated uridylation</article-title>. <source/>Cell Rep.
<volume>9</volume>, <fpage>1265</fpage>–<lpage>1272</lpage>. (<pub-id pub-id-type="doi">10.1016/j.celrep.2014.10.017</pub-id>)<pub-id pub-id-type="pmid">25457611</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C165">
<label>165</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>Small-molecule inhibitors disrupt let-7 oligouridylation and release the selective blockade of let-7 processing by LIN28</article-title>. <source/>Cell Rep.
<volume>23</volume>, <fpage>3091</fpage>–<lpage>3101</lpage>. (<pub-id pub-id-type="doi">10.1016/j.celrep.2018.04.116</pub-id>)<pub-id pub-id-type="pmid">29874593</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C166">
<label>166</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>MR</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Zcchc11 uridylates mature miRNAs to enhance neonatal IGF-1 expression, growth, and survival</article-title>. <source/>PLoS Genet.
<volume>8</volume>, <fpage>e1003105</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pgen.1003105</pub-id>)<pub-id pub-id-type="pmid">23209448</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C167">
<label>167</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Quinton</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Blahna</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Neilson</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ivanov</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Mizgerd</surname><given-names>JP</given-names></name></person-group>
<year>2009</year>
<article-title>Zcchc11-dependent uridylation of microRNA directs cytokine expression</article-title>. <source/>Nat. Cell Biol.
<volume>11</volume>, <fpage>1157</fpage>–<lpage>1163</lpage>. (<pub-id pub-id-type="doi">10.1038/ncb1931</pub-id>)<pub-id pub-id-type="pmid">19701194</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C168">
<label>168</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newman</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Mani</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Hammond</surname><given-names>SM</given-names></name></person-group>
<year>2011</year>
<article-title>Deep sequencing of microRNA precursors reveals extensive 3′ end modification</article-title>. <source/>RNA
<volume>17</volume>, <fpage>1795</fpage>–<lpage>1803</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.2713611</pub-id>)<pub-id pub-id-type="pmid">21849429</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C169">
<label>169</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thornton</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Jing</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sjekloca</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Grossi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sliz</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zon</surname><given-names>LI</given-names></name>, <name name-style="western"><surname>Gregory</surname><given-names>RI</given-names></name></person-group>
<year>2014</year>
<article-title>Selective microRNA uridylation by Zcchc6 (TUT7) and Zcchc11 (TUT4)</article-title>. <source/>Nucleic Acids Res.
<volume>42</volume>, <fpage>11 777</fpage>–<lpage>11 791</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gku805</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C170">
<label>170</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gutiérrez-Vázquez</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>3′ Uridylation controls mature microRNA turnover during CD4 T-cell activation</article-title>. <source/>RNA
<volume>23</volume>, <fpage>882</fpage>–<lpage>891</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.060095.116</pub-id>)<pub-id pub-id-type="pmid">28351886</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C171">
<label>171</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Nam</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Roth</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ransey</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Sliz</surname><given-names>P</given-names></name></person-group>
<year>2017</year>
<article-title>LIN28 zinc knuckle domain is required and sufficient to induce let-7 oligouridylation</article-title>. <source/>Cell Rep.
<volume>18</volume>, <fpage>2664</fpage>–<lpage>2675</lpage>. (<pub-id pub-id-type="doi">10.1016/j.celrep.2017.02.044</pub-id>)<pub-id pub-id-type="pmid">28297670</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C172">
<label>172</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doucet</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Wilusz</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Miyoshi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name></person-group>
<year>2015</year>
<article-title>A 3′ poly(A) tract is required for LINE-1 retrotransposition</article-title>. <source/>Mol. Cell
<volume>60</volume>, <fpage>728</fpage>–<lpage>741</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2015.10.012</pub-id>)<pub-id pub-id-type="pmid">26585388</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C173">
<label>173</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lackey</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Welch</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Marzluff</surname><given-names>WF</given-names></name></person-group>
<year>2016</year>
<article-title>TUT7 catalyzes the uridylation of the 3′ end for rapid degradation of histone mRNA</article-title>. <source/>RNA
<volume>22</volume>, <fpage>1673</fpage>–<lpage>1688</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.058107.116</pub-id>)<pub-id pub-id-type="pmid">27609902</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C174">
<label>174</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levine</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Chodchoy</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Marzluff</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Skoultchi</surname><given-names>AI</given-names></name></person-group>
<year>1987</year>
<article-title>Coupling of replication type histone mRNA levels to DNA synthesis requires the stem-loop sequence at the 3′ end of the mRNA</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>84</volume>, <fpage>6189</fpage>–<lpage>6193</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.84.17.6189</pub-id>)<pub-id pub-id-type="pmid">2888112</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C175">
<label>175</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pandey</surname><given-names>NB</given-names></name>, <name name-style="western"><surname>Marzluff</surname><given-names>WF</given-names></name></person-group>
<year>1987</year>
<article-title>The stem-loop structure at the 3′ end of histone mRNA is necessary and sufficient for regulation of histone mRNA stability</article-title>. <source/>Mol. Cell. Biol.
<volume>7</volume>, <fpage>4557</fpage>–<lpage>4559</lpage>. (<pub-id pub-id-type="doi">10.1128/MCB.7.12.4557</pub-id>)<pub-id pub-id-type="pmid">3437896</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C176">
<label>176</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osley</surname><given-names>MA</given-names></name></person-group>
<year>1991</year>
<article-title>The regulation of histone synthesis in the cell cycle</article-title>. <source/>Annu. Rev. Biochem.
<volume>60</volume>, <fpage>827</fpage>–<lpage>861</lpage>. (<pub-id pub-id-type="doi">10.1146/annurev.bi.60.070191.004143</pub-id>)<pub-id pub-id-type="pmid">1883210</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C177">
<label>177</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeLisle</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Graves</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Marzluff</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>LF</given-names></name></person-group>
<year>1983</year>
<article-title>Regulation of histone mRNA production and stability in serum-stimulated mouse 3T6 fibroblasts</article-title>. <source/>Mol. Cell. Biol.
<volume>3</volume>, <fpage>1920</fpage>–<lpage>1929</lpage>. (<pub-id pub-id-type="doi">10.1128/MCB.3.11.1920</pub-id>)<pub-id pub-id-type="pmid">6656760</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C178">
<label>178</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heintz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sive</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Roeder</surname><given-names>RG</given-names></name></person-group>
<year>1983</year>
<article-title>Regulation of human histone gene expression: kinetics of accumulation and changes in the rate of synthesis and in the half-lives of individual histone mRNAs during the HeLa cell cycle</article-title>. <source/>Mol. Cell. Biol.
<volume>3</volume>, <fpage>539</fpage>–<lpage>550</lpage>. (<pub-id pub-id-type="doi">10.1128/MCB.3.4.539</pub-id>)<pub-id pub-id-type="pmid">6406835</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C179">
<label>179</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marzluff</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Koreski</surname><given-names>KP</given-names></name></person-group>
<year>2017</year>
<article-title>Birth and death of histone mRNAs</article-title>. <source/>Trends Genet.
<volume>33</volume>, <fpage>745</fpage>–<lpage>759</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tig.2017.07.014</pub-id>)<pub-id pub-id-type="pmid">28867047</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C180">
<label>180</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meaux</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Holmquist</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Marzluff</surname><given-names>WF</given-names></name></person-group>
<year>2018</year>
<article-title>Role of oligouridylation in normal metabolism and regulated degradation of mammalian histone mRNAs</article-title>. <source/>Phil. Trans. R. Soc. B
<volume>373</volume>, <fpage>20180170</fpage> (<pub-id pub-id-type="doi">10.1098/rstb.2018.0170</pub-id>)<pub-id pub-id-type="pmid">30397106</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C181">
<label>181</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ha</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>VN</given-names></name></person-group>
<year>2014</year>
<article-title>TAIL-seq: genome-wide determination of poly(A) tail length and 3′ end modifications</article-title>. <source/>Mol. Cell
<volume>53</volume>, <fpage>1044</fpage>–<lpage>1052</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2014.02.007</pub-id>)<pub-id pub-id-type="pmid">24582499</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C182">
<label>182</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ha</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kwon</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Simanshu</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>VN</given-names></name></person-group>
<year>2014</year>
<article-title>Uridylation by TUT4 and TUT7 marks mRNA for degradation</article-title>. <source/>Cell
<volume>159</volume>, <fpage>1365</fpage>–<lpage>1376</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2014.10.055</pub-id>)<pub-id pub-id-type="pmid">25480299</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C183">
<label>183</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lubas</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Damgaard</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Tomecki</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Cysewski</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Dziembowski</surname><given-names>A</given-names></name></person-group>
<year>2013</year>
<article-title>Exonuclease hDIS3L2 specifies an exosome-independent 3′-5′ degradation pathway of human cytoplasmic mRNA</article-title>. <source/>EMBO J.
<volume>32</volume>, <fpage>1855</fpage>–<lpage>1868</lpage>. (<pub-id pub-id-type="doi">10.1038/emboj.2013.135</pub-id>)<pub-id pub-id-type="pmid">23756462</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C184">
<label>184</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Kiledjian</surname><given-names>M</given-names></name></person-group>
<year>2007</year>
<article-title>3′ terminal oligo U-tract-mediated stimulation of decapping</article-title>. <source/>RNA
<volume>13</volume>, <fpage>2356</fpage>–<lpage>2365</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.765807</pub-id>)<pub-id pub-id-type="pmid">17942740</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C185">
<label>185</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Łabno</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tomecki</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dziembowski</surname><given-names>A</given-names></name></person-group>
<year>2016</year>
<article-title>Cytoplasmic RNA decay pathways—enzymes and mechanisms</article-title>. <source/>Biochim. Biophys. Acta Mol. Cell Res.
<volume>1863</volume>, <fpage>3125</fpage>–<lpage>3147</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbamcr.2016.09.023</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C186">
<label>186</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rissland</surname><given-names>OS</given-names></name>, <name name-style="western"><surname>Norbury</surname><given-names>CJ</given-names></name></person-group>
<year>2009</year>
<article-title>Decapping is preceded by 3′ uridylation in a novel pathway of bulk mRNA turnover</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>16</volume>, <fpage>616</fpage>–<lpage>623</lpage>. (<pub-id pub-id-type="doi">10.1038/nsmb.1601</pub-id>)<pub-id pub-id-type="pmid">19430462</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C187">
<label>187</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>YUNS</given-names></name>, <name name-style="western"><surname>Patena</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Leavitt</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Mcmanus</surname><given-names>MT</given-names></name></person-group>
<year>2012</year>
<article-title>Widespread RNA 3-end oligouridylation in mammals</article-title>. <source/>Bioinformatics, <fpage>394</fpage>–<lpage>401</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.029306.111.function</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C188">
<label>188</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ustianenko</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Pasulka</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Feketova</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Bednarik</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zigackova</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fortova</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zavolan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vanacova</surname><given-names>S</given-names></name></person-group>
<year>2016</year>
<article-title>TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs</article-title>. <source/>EMBO J.
<volume>35</volume>, <fpage>2179</fpage>–<lpage>2191</lpage>. (<pub-id pub-id-type="doi">10.15252/embj.201694857</pub-id>)<pub-id pub-id-type="pmid">27647875</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C189">
<label>189</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Whangbo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>McCrossan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sanborn</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Basar</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Walch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lieberman</surname><given-names>J</given-names></name></person-group>
<year>2015</year>
<article-title>Apoptosis triggers specific, rapid, and global mRNA decay with 3′ uridylated intermediates degraded by DIS3L2</article-title>. <source/>Cell Rep.
<volume>11</volume>, <fpage>1079</fpage>–<lpage>1089</lpage>. (<pub-id pub-id-type="doi">10.1016/j.celrep.2015.04.026</pub-id>)<pub-id pub-id-type="pmid">25959823</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C190">
<label>190</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Del Prete</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Robles</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Guáo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Martínez-A</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Izquierdo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Garcia-Sanz</surname><given-names>JA</given-names></name></person-group>
<year>2002</year>
<article-title>Degradation of cellular mRNA is a general early apoptosis-induced event</article-title>. <source/>FASEB J.
<volume>16</volume>, <fpage>2003</fpage>–<lpage>2005</lpage>. (<pub-id pub-id-type="doi">10.1096/fj.02-0392fje</pub-id>)<pub-id pub-id-type="pmid">12397088</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C191">
<label>191</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajani</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Walch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Martinvalet</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Lieberman</surname><given-names>J</given-names></name></person-group>
<year>2012</year>
<article-title>Alterations in RNA processing during immune-mediated programmed cell death</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>109</volume>, <fpage>8688</fpage>–<lpage>8693</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1201327109</pub-id>)<pub-id pub-id-type="pmid">22589304</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C192">
<label>192</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>Terminal uridylyltransferases execute programmed clearance of maternal transcriptome in vertebrate embryos</article-title>. <source/>Mol. Cell
<volume>70</volume>, <fpage>72</fpage>–<lpage>82</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2018.03.004</pub-id>)<pub-id pub-id-type="pmid">29625039</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C193">
<label>193</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wahl</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Will</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Lührmann</surname><given-names>R</given-names></name></person-group>
<year>2009</year>
<article-title>The spliceosome: design principles of a dynamic RNP machine</article-title>. <source/>Cell
<volume>136</volume>, <fpage>701</fpage>–<lpage>718</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2009.02.009</pub-id>)<pub-id pub-id-type="pmid">19239890</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C194">
<label>194</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Englbrecht</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chari</surname><given-names>A</given-names></name></person-group>
<year>2011</year>
<article-title>Biogenesis of spliceosomal small nuclear ribonucleoproteins</article-title>. <source/>Wiley Interdiscip. Rev. RNA
<volume>2</volume>, <fpage>718</fpage>–<lpage>731</lpage>. (<pub-id pub-id-type="doi">10.1002/wrna.87</pub-id>)<pub-id pub-id-type="pmid">21823231</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C195">
<label>195</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pirouz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Munafò</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gregory</surname><given-names>RI</given-names></name></person-group>
<year>2016</year>
<article-title>Dis3l2-mediated decay is a quality control pathway for noncoding RNAs</article-title>. <source/>Cell Rep.
<volume>16</volume>, <fpage>1861</fpage>–<lpage>1873</lpage>. (<pub-id pub-id-type="doi">10.1016/j.celrep.2016.07.025</pub-id>)<pub-id pub-id-type="pmid">27498873</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C196">
<label>196</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lardelli</surname><given-names>RM</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>Biallelic mutations in the 3′ exonuclease TOE1 cause pontocerebellar hypoplasia and uncover a role in snRNA processing</article-title>. <source/>Nat. Genet.
<volume>49</volume>, <fpage>457</fpage>–<lpage>464</lpage>. (<pub-id pub-id-type="doi">10.1038/ng.3762</pub-id>)<pub-id pub-id-type="pmid">28092684</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C197">
<label>197</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dieci</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Fiorino</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Castelnuovo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Teichmann</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pagano</surname><given-names>A</given-names></name></person-group>
<year>2007</year>
<article-title>The expanding RNA polymerase III transcriptome</article-title>. <source/>Trends Genet.
<volume>23</volume>, <fpage>614</fpage>–<lpage>622</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tig.2007.09.001</pub-id>)<pub-id pub-id-type="pmid">17977614</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C198">
<label>198</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turowski</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Tollervey</surname><given-names>D</given-names></name></person-group>
<year>2016</year>
<article-title>Transcription by RNA polymerase III: insights into mechanism and regulation</article-title>. <source/>Biochem. Soc. Trans.
<volume>44</volume>, <fpage>1367</fpage>–<lpage>1375</lpage>. (<pub-id pub-id-type="doi">10.1042/BST20160062</pub-id>)<pub-id pub-id-type="pmid">27911719</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C199">
<label>199</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gopinath</surname><given-names>SCB</given-names></name>, <name name-style="western"><surname>Wadhwa</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>PKR</given-names></name></person-group>
<year>2010</year>
<article-title>Expression of noncoding vault RNA in human malignant cells and its importance in mitoxantrone resistance</article-title>. <source/>Mol. Cancer Res.
<volume>8</volume>, <fpage>1536</fpage>–<lpage>1546</lpage>. (<pub-id pub-id-type="doi">10.1158/1541-7786.MCR-10-0242</pub-id>)<pub-id pub-id-type="pmid">20881010</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C200">
<label>200</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amort</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nachbauer</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Tuzlak</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kieser</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Schepers</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Villunger</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Polacek</surname><given-names>N</given-names></name></person-group>
<year>2015</year>
<article-title>Expression of the vault RNA protects cells from undergoing apoptosis</article-title>. <source/>Nat. Commun.
<volume>6</volume>, <fpage>7030</fpage> (<pub-id pub-id-type="doi">10.1038/ncomms8030</pub-id>)<pub-id pub-id-type="pmid">25952297</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C201">
<label>201</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Persson</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kvist</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vallon-Christersson</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Medstrand</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Borg</surname><given-names>Å</given-names></name>, <name name-style="western"><surname>Rovira</surname><given-names>C</given-names></name></person-group>
<year>2009</year>
<article-title>The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs</article-title>. <source/>Nat. Cell Biol.
<volume>11</volume>, <fpage>1268</fpage>–<lpage>1271</lpage>. (<pub-id pub-id-type="doi">10.1038/ncb1972</pub-id>)<pub-id pub-id-type="pmid">19749744</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C202">
<label>202</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nicolas</surname><given-names>FE</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Csorba</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Turnbull</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dalmay</surname><given-names>T</given-names></name></person-group>
<year>2012</year>
<article-title>Biogenesis of Y RNA-derived small RNAs is independent of the microRNA pathway</article-title>. <source/>FEBS Lett.
<volume>586</volume>, <fpage>1226</fpage>–<lpage>1230</lpage>. (<pub-id pub-id-type="doi">10.1016/j.febslet.2012.03.026</pub-id>)<pub-id pub-id-type="pmid">22575660</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C203">
<label>203</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ridanpää</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2001</year>
<article-title>Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia</article-title>. <source/>Cell
<volume>104</volume>, <fpage>195</fpage>–<lpage>203</lpage>. (<pub-id pub-id-type="doi">10.1016/S0092-8674(01)00205-7</pub-id>)<pub-id pub-id-type="pmid">11207361</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C204">
<label>204</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name></person-group>
<year>2016</year>
<article-title>Widespread 3′-end uridylation in eukaryotic RNA viruses</article-title>. <source/>Sci. Rep.
<volume>6</volume>, <fpage>25454</fpage> (<pub-id pub-id-type="doi">10.1038/srep25454</pub-id>)<pub-id pub-id-type="pmid">27151171</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C205">
<label>205</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le Pen</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>Terminal uridylyltransferases target RNA viruses as part of the innate immune system</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>25</volume>, <fpage>778</fpage>–<lpage>786</lpage>. (<pub-id pub-id-type="doi">10.1038/s41594-018-0106-9</pub-id>)<pub-id pub-id-type="pmid">30104661</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C206">
<label>206</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warkocki</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Krawczyk</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Adamska</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bijata</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Garcia-Perez</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Dziembowski</surname><given-names>A</given-names></name></person-group>
<year>2018</year>
<article-title>Uridylation by TUT4/7 restricts retrotransposition of human LINE-1s</article-title>. <source/>Cell
<volume>175</volume>, <fpage>1537</fpage>–<lpage>1548</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2018.07.022</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C207">
<label>207</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cordaux</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Batzer</surname><given-names>MA</given-names></name></person-group>
<year>2009</year>
<article-title>The impact of retrotransposons on human genome evolution</article-title>. <source/>Nat. Rev. Genet.
<volume>10</volume>, <fpage>691</fpage>–<lpage>703</lpage>. (<pub-id pub-id-type="doi">10.1038/nrg2640</pub-id>)<pub-id pub-id-type="pmid">19763152</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C208">
<label>208</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faulkner</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Garcia-Perez</surname><given-names>JL</given-names></name></person-group>
<year>2017</year>
<article-title>L1 mosaicism in mammals: extent, effects, and evolution</article-title>. <source/>Trends Genet.
<volume>33</volume>, <fpage>802</fpage>–<lpage>816</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tig.2017.07.004</pub-id>)<pub-id pub-id-type="pmid">28797643</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C209">
<label>209</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muotri</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>VT</given-names></name>, <name name-style="western"><surname>Marchetto</surname><given-names>MCN</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Gage</surname><given-names>FH</given-names></name></person-group>
<year>2005</year>
<article-title>Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition</article-title>. <source/>Nature
<volume>435</volume>, <fpage>903</fpage>–<lpage>910</lpage>. (<pub-id pub-id-type="doi">10.1038/nature03663</pub-id>)<pub-id pub-id-type="pmid">15959507</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C210">
<label>210</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coufal</surname><given-names>NG</given-names></name><etal>et al.</etal></person-group>
<year>2009</year>
<article-title>L1 retrotransposition in human neural progenitor cells</article-title>. <source/>Nature
<volume>460</volume>, <fpage>1127</fpage>–<lpage>1131</lpage>. (<pub-id pub-id-type="doi">10.1038/nature08248</pub-id>)<pub-id pub-id-type="pmid">19657334</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C211">
<label>211</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baillie</surname><given-names>JK</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Somatic retrotransposition alters the genetic landscape of the human brain</article-title>. <source/>Nature
<volume>479</volume>, <fpage>534</fpage>–<lpage>537</lpage>. (<pub-id pub-id-type="doi">10.1038/nature10531</pub-id>)<pub-id pub-id-type="pmid">22037309</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C212">
<label>212</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Devine</surname><given-names>SE</given-names></name></person-group>
<year>2017</year>
<article-title>The role of somatic L1 retrotransposition in human cancers</article-title>. <source/>Viruses
<volume>9</volume>, <fpage>131</fpage> (<pub-id pub-id-type="doi">10.3390/v9060131</pub-id>)</mixed-citation>
</ref>
<ref id="RSTB20180162C213">
<label>213</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monot</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kuciak</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Viollet</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mir</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Gabus</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Darlix</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Cristofari</surname><given-names>G</given-names></name></person-group>
<year>2013</year>
<article-title>The specificity and flexibility of L1 reverse transcription priming at imperfect T-tracts</article-title>. <source/>PLoS Genet.
<volume>9</volume>, <fpage>e1003499</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pgen.1003499</pub-id>)<pub-id pub-id-type="pmid">23675310</pub-id></mixed-citation>
</ref>
<ref id="RSTB20180162C214">
<label>214</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Razew</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>Structural analysis of mtEXO mitochondrial RNA degradosome reveals tight coupling of nuclease and helicase components</article-title>. <source/>Nat. Commun.
<volume>9</volume>, <fpage>97</fpage> (<pub-id pub-id-type="doi">10.1038/s41467-017-02570-5</pub-id>)<pub-id pub-id-type="pmid">29311576</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>